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On 12 November 2018, the Department of 
Health’s Drugs Policy Unit and the Health 
Research Board (HRB) will host the first annual 
National Drugs Forum in the Aviva Stadium. 
The objectives of the forum are: 
•  To support evidence-informed practice and 
service delivery 
•  To promote participation of communities, 
service users, and their families in national 
structures
•  To strengthen the implementation and 
performance of the national drugs strategy.
 
The theme for the forum is Working better together by 
developing communities of practice. This event aims to 
strengthen the capacity of existing communities of practice 
and to provide examples for collaborative working across the 
statutory, community, and voluntary sectors. 
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In brief
The objectives and actions of the national 
drugs strategy, Reducing harm, supporting 
recovery, are underpinned by the values of 
equity and partnership and a commitment to an 
evidence-informed approach. The involvement 
of communities in the response to problem drug 
use is key to realising the strategy’s aims. The 
strategy also underlines the place of evidence in 
service development and delivery. It recognises 
how important it is to engage stakeholders both 
in the implementation of research findings and in 
sharing learned experience. 
In November 2018, the Department of Health and 
the Health Research Board will host a national forum 
that will provide an opportunity for community-based 
services to inform colleagues about their work, to 
exchange knowledge around what works, and to identify 
information gaps. It will recognise the dynamism and 
commitment of these services, enable shared learning 
and encourage discussion among practitioners, activists, 
and administrators who face similar challenges. This 
event aims to strengthen the capacity of existing 
communities of practice and provide examples for new 
networks and collaborative working across the statutory, 
community, and voluntary sectors. 
The idea of communities of practice in drugs and 
alcohol services builds on the origin of the concept 
in other spheres that sought more effective ways of 
learning while working. Communities of practice are 
usually defined in terms of groups of people prepared 
to work together to find solutions to a problem they 
have in common. The opportunity offered means that 
information and advice can be shared and existing 
tools and methods can be adapted and applied to new 
situations. If maintained, the community of practice can 
share a body of knowledge and develop new practices 
and approaches.
Identifying interventions which have been shown to work 
is an essential part of developing effective responses 
but, just as importantly, is identifying what evidence 
is relevant to the national situation, where the gaps in 
evidence are, and how will we know if the response is 
effective. These are all questions that can be answered 
more convincingly if those who face the same type 
of problem and learning occurs through practice and 
interaction with colleagues. Participants in the forum 
will hear from services with similar concerns to them. 
They can share knowledge from their own experience 
and learn about ways of continuing this interaction so 
that a common approach can be developed, based on 
evidence but also on the practical knowledge built up 
throughout successive drugs strategies. 
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The forum will feature two keynote presentations from 
international experts, followed by four parallel workshops. Dr 
Karen Minyard from Georgia Health Policy Center in Georgia 
State University will speak on the centre’s recent evidence 
review on dual diagnosis and will describe how communities of 
practices can be effective vehicles for transferring evidence 
into practical work. Professor Harry Sumnall of Liverpool 
John Moores University will examine the evidence base for 
interventions in the prevention and social reintegration 
field. Both are internationally renowned scholars with vast 
experience in policy development and knowledge transfer.
Workshops
The following four workshops will take place: 
1 Supporting prevention work in the community. 
2  Dual diagnosis: using partnership and peer support as 
resources in treatment. 
3 The role of social reintegration in recovery. 
4  Harm reduction services: engaging with people who  
use drugs.
A report on the forum will identify the key message from 
each of these workshops and suggest ways of developing 
communities of practices and learning from ongoing work in 
each of these areas throughout the country.
You can register for the conference by visiting the HRB 
National Drugs Library website at www.drugsandalcohol.ie 
and following the link to the Eventbrite registration page.
Brian Galvin
National Drugs Forum continued
Each of these goals is supported by a set of objectives 
and actions. Responsibility for delivering on them is 
spread across government departments, with actions 
that cover a wide variety of areas. These include schools, 
higher education institutions, health and social services, 
workplaces, youth services, and the wider community.
The findings of the consultation (as outlined below) were 
used to heavily inform the strategy. As with the consultation, 
the strategy identifies high levels of smoking, drug use, and 
alcohol consumption as one of the challenges faced by 
LGBTI+ young people in Ireland. It has a specific action to 
address young people’s call for more alcohol-free spaces 
in which to meet. Under the first goal, it commits to ‘map 
existing LGBTI+ youth services and groups and increase the 
awareness of these services and consider increasing the 
provision of non-alcoholic safe spaces which are inclusive 
of LGBTI+ young people’ (p. 21). Drug and alcohol use is not 
dealt elsewhere in the strategy but reference is made to the 
national drug and alcohol strategy.4
The consultation
There were two key strands to the consultation: an online 
survey and a series of consultation events. The consultations 
reached a total of 3,882 young people from across Ireland 
(n=3710 young people completed the survey; n=172 young 
people attended one of seven consultation events). While 
most of the participants identified themselves as a member 
of the LGBTI+ community (69% of survey respondents and 
93% of event participants), the consultation was not limited 
to this group. 
POLICY AND LEGISLATION 
LGBTI+ Youth 
Strategy
The Department of Children and Youth Affairs (DCYA) has 
published the world’s first national LGBTI+ Youth Strategy.1 
This follows on from a commitment in the 2016 Programme 
for Government to ‘develop an LGBT Youth Strategy that 
will encompass education, youth services, mental health 
and other issues’ (p. 106).2 A key part of the process of 
developing the strategy was a DCYA-led consultation with 
young people from across Ireland, the findings of which have 
also been published.3 
LGBTI+ Youth Strategy
The LGBTI+ Youth Strategy document is structured around 
three goals:
1  Create a safe, supportive and inclusive environment for 
LGBTI+ young people.
2  Improve the mental, physical and sexual health and 
wellbeing of the entire LGBTI+ community.
3  Develop the research and data environment to better 
understand the lives of LGBTI+ young people.
4
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Participants identified a culture of drug and alcohol misuse 
within their community, which had a negative impact on 
people’s mental health and wellbeing. Explanations provided 
for this higher level of use included that substances were used 
as ‘bad coping mechanisms to deal with exclusion’ (p. 80).3 
Linked to a call by participants for improved access and 
delivery of mental health services was a call for improved 
access to early intervention and other drug-related services.
Concerns were also expressed about the lack of alcohol-
free spaces and places for young LGBTI+ people to meet 
up. People’s experiences were that many of the ‘safe’ social 
spaces for meeting up were nightclubs that were also ‘hyper 
sexualised’ with a focus on ‘hooking up’ (p. 23). The shortage 
of safe alcohol-free spaces presented particular challenges 
and risks for those who were under 18 years of age.
Lucy Dillon
1 Department of Children and Youth Affairs (2018) LGBTI+ national 
youth strategy 2018–2020. Dublin: Department of Children and 
Youth Affairs. https://www.drugsandalcohol.ie/29267/
2 Government of Ireland (2016) A programme for a partnership 
government. Dublin: Department of the Taoiseach.  
https://www.drugsandalcohol.ie/25508/
3 Fullerton D, McGrellis S, Power I, McKenna O and Velthuis S (2017) 
LGBTI+ national youth strategy: report of the consultations with 
young people in Ireland. Dublin: Department of Children and 
Youth Affairs. https://www.drugsandalcohol.ie/28323/
4 Department of Health (2017) Reducing harm, supporting  
recovery: a health-led response to drug and alcohol use in  
Ireland 2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/ 
The consultations focused on three broad questions: 
1  What is positive about being a young LGBTI+ person in 
Ireland today? (Positives)
2  What issues are faced by young LGBTI+ people in Ireland 
today? (Issues)
3  What changes would improve the lives of young LGBTI+ 
people? (Changes)
The findings
The extensive body of data collected was analysed 
thematically. A broad range of themes was identified, a 
detailed account of which is beyond the scope of this article. 
However, illustrations of the key findings in relation to each 
of the consultation’s three questions are:
• Positives: There is less discrimination and an increased 
sense of acceptance and social support than there has 
been in the past. Examples of this included positive legal 
reform around marriage equality and equal status, and 
gender recognition legislation.
• Issues: Despite improvements, there is an ongoing sense 
of discrimination and stigma attached to the LGBT 
community. Participants reported experiences of bullying 
and harassment, isolation and exclusion, among others.
• Changes: Changes to education within schools and 
improved training for professionals on LGBTI inclusion 
and related issues were the most commonly cited areas 
of need.
The LGBTI+ community is identified in the national drug 
and alcohol strategy as one of a number of groups who 
experience a higher risk of problematic substance use than 
the general population.4 
LGBTI+ Youth Strategy 
continued
The strands and their aims are: 
1  Data working strand: To improve access and use of data 
and information relating to children, young people, and 
their families by aligning and developing what currently 
exists in this area. 
2  Evidence working strand: To harness the learning from 
prevention and early intervention initiatives and research 
and actively support the use of this learning as a source 
and resource to inform planning, delivery, evaluation, and 
continuous improvements. 
3  Professional development and capacity-building working 
strand: To enhance the capacity and skills development 
of policymakers, providers and practitioners in the 
appraisal and application of evidence-informed 
approaches in prevention and early intervention for 
children and young people through capacity building and 
development. 
4  Quality working strand: To align, enhance and sustain 
quality in prevention and early intervention as it relates 
to the development and delivery of policy, provision, and 
practice for children and young people.
Quality and Capacity 
Building Initiative 
(QCBI) 
The Quality and Capacity Building Initiative (QCBI) of the 
Department of Children and Youth Affairs (DCYA) has been 
under development since 2016, with progress being made on 
implementing some key components over 2017/18. The QCBI 
aims to take a coordinated approach to enhancing capacity, 
knowledge and quality in prevention, and early intervention 
for children, young people and their families, with a focus on 
those at risk of developing poor outcomes. It aims to ensure 
that effective practice is harnessed and applied across the 
relevant services and supports. There are four key strands to 
the initiative that set out to embed and enhance prevention 
and early intervention in children and young people’s policy, 
service provision, and practice. 
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QCBI continued • Provide details of the ‘most reliable’ evaluations that 
have been carried out in Ireland and globally on the 
programme.
• Provide contact details of licence holders and/or 
individuals/organisations that have implemented the 
programme in Ireland or Europe.
• Provide technical guidance on evaluations, analyses, and 
further suggested reading related to the programme.
Work on the matrix is expected to begin in 2018, with a 
contract running to the end of 2020.
3. Professional development and capacity-building  
working strand
The planned output under the professional development and 
capacity-building working strand is a standardised module 
of training in prevention and early intervention, with the 
associated supports. A mapping exercise of existing training 
in this field has been carried out.
4. Quality working strand
While there have been no specific deliverables completed 
under the quality strand, much of the work being carried out 
under the other three strands is expected to impact on the 
quality of service design and delivery.
Lucy Dillon 
1 Department of Children and Youth Affairs (2018) Request  
for tenders 27 April 2018 for the development of evidence 
matrix for the Quality and Capacity Building Initiative.  
Dublin: Department of Children and Youth Affairs.  
https://www.drugsandalcohol.ie/29299/
2 Further information is available at: https://www.dcya.gov.ie/cat/
EN/Quality-and-Capacity-Building-Initiative/1406.htm
3 Department of Children and Youth Affairs (2014) Better 
outcomes, brighter futures: the national policy framework for 
children and young people 2014–2020. Dublin: Department of 
Children and Youth Affairs. https://www.drugsandalcohol.ie/21773
Some key activities carried out under each strand are  
as follows:
1. Data working strand
Development work is underway on an actively resourced data 
hub that includes data relating to children and young people 
that can be used by all stakeholders.
2. Evidence working strand: Evidence Matrix
In April 2018, the DCYA sent out a call for tenders to develop 
an ‘evidence matrix’.1 The matrix will be an online tool that 
will be hosted on the QCBI area of the DCYA website.2 It is 
described as an ‘open access online guide/clearinghouse 
which will provide details and rated assessment of the costs 
and standards of evidence of impact of prevention and 
early intervention evidence based programmes globally and 
in Ireland’ (p. 3).1 The focus is on manualised programmes. 
The matrix will support stakeholders to identify, select, and 
implement the right evidence-based programmes to address 
one of a set of five broad national outcomes for children 
set out in the Better outcomes, brighter futures3 policy 
document, which includes those related to the prevention  
of drug and alcohol use. While the scope of programmes to 
be included in the matrix is broader than just the prevention 
of drug use, it will be a useful resource for those working in 
the sector. 
Among the requirements of the matrix are that it will:
• Provide details and an assessment of evidence and costs 
for prevention and early intervention-based programmes 
commonly implemented for children and young people 
services globally or in Ireland.
• Rate the standard of evidence of impact available on 
each programme included on the online matrix.
• Rate the costs of the programmes.
• Provide details of each programme, including how  
it works.
• Provide information on how the programme should be 
implemented and the resources required to implement  
it effectively.
to leave no one behind and to end all forms of poverty, 
fight inequalities, and tackle climate change. The 17 goals 
are a call to action aimed at all countries, poor, rich and 
middle-income, to promote prosperity while protecting the 
planet. Goal 3 calls for countries to ‘ensure healthy lives and 
promote well-being for all at all ages’. As one of the 13 related 
targets, it encourages action by countries to ‘strengthen 
the prevention and treatment of substance abuse, including 
narcotic drug abuse and harmful use of alcohol’.
The SDGs are a compass for aligning countries’ plans with their 
global commitments, and the implementation and success 
of the goals will rely on each country’s own sustainable 
development policies, plans and programmes. At a national 
level, governments will develop individual indicators to 
monitor progress made towards each goal and target; while 
at a global level, a global indicator framework was agreed and 
adopted by the UN General Assembly on 6 July 2017.2 
Drug and alcohol 
abuse targeted in 
UN’s 2030 Agenda 
and 17 Sustainable 
Development Goals
In September 2015, at an historic United Nations (UN) Summit, 
the 193 member countries of the UN adopted the 2030 
Agenda for Sustainable Development.1 Within that resolution, 
17 Sustainable Development Goals (SDGs) and 169 related 
targets were announced. The objectives of this agenda are 
6
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communities.
• Develop sound and comprehensive evidence-informed 
policies and actions. 
On a legislative level, with the proposed Public Health 
(Alcohol) Bill 2015, the Government aims to reduce alcohol 
consumption in Ireland to the OECD average of 9.1 litres of 
pure alcohol per capita by 2020.
In addition, the Government has undertaken to produce 
national reports on its implementation of the goals every 
two years and voluntary national reviews every four years, 
beginning in 2018. 
Michael O’Sullivan
1 Further information on the 2030 Agenda, goals and 
targets is available online at: https://www.un.org/
sustainabledevelopment/
2 Further information on the global indicators is available online at: 
https://unstats.un.org/sdgs/ 
3 Department of Communications, Climate Action and Environment 
(2018) The sustainable development goals national implementation 
plan 2018–2020. Dublin: Government of Ireland. Available online 
at: https://www.dccae.gov.ie/documents/DCCAE-National-
Implement-Plan.pdf 
4  Department of Health (2017) Reducing harm, supporting  
recovery: a health-led response to drug and alcohol use in  
Ireland 2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/
 
Under the drug and alcohol target, the indicators in use 
globally are: 
• Coverage of treatment interventions (pharmacological, 
psychosocial, and rehabilitation and aftercare services) 
for substance use disorders.
• Harmful use of alcohol, defined according to the national 
context as alcohol per capita consumption (aged 15 years 
and older) within a calendar year in litres of pure alcohol. 
In 2018 in Ireland, the Department of Communications, 
Climate Action and Environment (DCCAE) published The 
sustainable development goals national implementation 
plan 2018–20203 detailing Ireland’s response. It identifies 
the national policies and their key objectives that align 
with each global indicator. On a drug policy level, in its 
strategy, Reducing harm, supporting recovery: a health-led 
response to drug and alcohol use in Ireland 2017–2025,4 the 
Department of Health aims to:
• Promote and protect health and wellbeing.
• Minimise the harms caused by the use and misuse of 
substances and promote rehabilitation and recovery.
• Address the harms of drug markets and reduce access to 
drugs for harmful use.
Sustainable Development Goals 
continued
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Overview
The proportion of new cases decreased over the period from 
42.5% in 2010 to 38.2% in 2016 (see Table 2). The proportion 
of previously treated cases increased from 55% in 2010 to 
57.8% in 2016. The increase in the number of previously 
treated cases is an indicator of the chronic, relapsing nature 
of addiction.
In 2016, the median age (age at which half the population is 
older and half is younger) of those treated was 30 years. The 
median age differed depending on whether the case was new 
(25 years) or previously treated (32 years). Over the reporting 
period, the median age of all cases treated increased from 
28 years in 2010 to 30 years in 2016.
Similar to previous years, the majority of those treated in 
2016 were male (72.4%). The proportion of cases that were 
homeless increased from 5.1% in 2010 to 9.6% in 2016.
The proportion of cases that identified as Travellers 
increased from 2.8% in 2010 to 3.2% in 2016. The proportion 
of Travellers in the general population is 0.7% (2016 Census).2 
In 2016, two-thirds of all cases (66.2%) were unemployed. 
Unemployment rates in this group did not drop below 60% 
for all of the years reported. Unemployment rates were 
higher among previously treated cases.
Opiates (mainly heroin) continued to be the most commonly 
reported drug over the reporting period. The proportion 
of cases treated decreased from 58.1% in 2010 to 47% in 
2016. Cannabis was the second most common drug reported 
among those treated. The proportion of cases reporting 
problem cannabis use increased by 23% in 2010 to 26.4% 
in 2016. Cannabis is the most common drug reported by 
new cases. Cocaine remained the third most common drug 
reported and, in 2016, 12.3% of cases reported problem 
cocaine use, the highest proportion reported since 2010.
PREVALENCE AND CURRENT SITUATION 
Drug treatment 
figures from the 
NDTRS, 2010—2016
The National Drug Treatment Reporting System (NDTRS) 
published its latest figures on treated problem drug use 
(excluding alcohol) in May 2018.1 These figures exclude those 
who reported alcohol as their primary problem substance as 
this will be reported in a separate bulletin. In the seven-year 
period, 2010—2016, 63,187 cases were treated for problem 
drug use (excluding alcohol). The number of cases increased 
from 8,806 in 2010 to 9,227 in 2016. 
In 2016, the NDTRS began the implementation of a new 
web-based data collection tool; this has significantly 
changed the way the NDTRS works and the transition may 
have contributed to the reduction in the number of cases 
reported for 2016. While fewer cases were reported for 
2016 than 2015, the trends remained consistent with those 
reported for 2010 to 2015.
Service provider
The majority of cases were treated in outpatient facilities 
(63.4%) over the period, similar to previous years (see Table 
1). The proportion of cases treated in prison decreased 
slightly from 10.6% to 8% over the reporting period. In 2016, 
the proportion of cases treated in residential facilities was 
20.4%, an increase from 14% in 2010.
Table 1: Number of cases treated for problem drug use, by type of service provider, NDTRS 2010 to 2016
 2010 2011 2012 2013 2014 2015 2016
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
All cases 8806 8361 8005 9006 9890 9892 9227
Outpatient 5563 (63.2) 5623 (67.3) 5299 (66.2) 5998 (66.6) 6251 (63.2) 5818 (58.8) 5481 (59.4)
Inpatient* 1232 (14.0) 1107 (13.2) 1124 (14.0) 1233 (13.7) 1348 (13.6) 1779 (18.0) 1885 (20.4)
Low 
threshold
793 (9.0) 642 (7.7) 711 (8.9) 812 (9.0) 1190 (12.0) 1197 (12.1) 886 (9.6)
Prison 930 (10.6) 761 (9.1) 642 (8.0) 747 (8.3) 844 (8.5) 827 (8.4) 737 (8.0)
General 
practitioner
288 (3.3) 228 (2.7) 229 (2.9) 216 (2.4) 257 (2.6) 271 (2.7) 238 (2.6)
* Includes any service where the client stays overnight, e.g. inpatient detoxification, therapeutic communities, respite, and step-down.
Table 2: Number of cases treated for problem drug use, by treatment status, NDTRS 2010 to 2016
2010 2011 2012 2013 2014 2015 2016
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Revised total 8806 8361 8005 9006 9890 9892 9227
New cases 3741 (42.5) 3316 (39.7) 3272 (40.9) 3475 (38.6) 3776 (38.2) 3742 (37.8) 3526 (38.2)
Previously 
treated 
cases
4842 (55.0) 4862 (58.2) 4518 (56.4) 5239 (58.2) 5643 (57.1) 5855 (59.2) 5335 (57.8)
Treatment 
status 
unknown
223 (2.5) 183 (2.2) 215 (2.7) 292 (3.2) 471 (4.0) 295 (3.0) 366 (4.0)
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Adult smoking in 
Ireland: findings from 
the Healthy Ireland 
Survey and the Irish 
Longitudinal Study 
on Ageing 
Smoking is the leading cause of preventable death in Ireland, 
with over 100 people dying from diseases caused by tobacco 
use each week; this represents almost one in five of all 
deaths.1 The Health Service Executive (HSE) has recently 
published a report detailing findings from an Irish study that 
examined smoking behaviours in Ireland among adults aged 
15+ using data from the Healthy Ireland Survey and The Irish 
Longitudinal Study on Ageing (TILDA).2 Key findings from the 
report are discussed below.
Characteristics of adults who smoke in Ireland
It was found that one in five Irish adults smoke daily, which 
equates to approximately 714,000 current adult smokers 
in Ireland. The highest prevalence of current smoking was 
among 25–34-year-olds. Male subjects were more likely to 
smoke and to have begun smoking at an earlier age than 
females. Individuals who were current smokers were also 
more likely to be single, unemployed or in a routine manual 
occupation.
The impact of smoking on health and wellbeing
Results from both surveys showed that people who smoke 
are more likely to self-report poor health – both poorer 
physical health and mental health. The prevalence of 
smoking-related chronic diseases was found to be highest 
among ex-smokers. In addition, among all people who 
smoke, the prevalence of these diseases was related to the 
amount smoked. It was also found that survey participants 
who smoke experience limitations in activities of daily living 
as a result of their smoking, particularly in later life and that, 
again, the prevalence of limitations is related to the amount 
smoked. The study also found that people who smoke are 
more likely to utilise healthcare services, at all ages.
Intention to quit smoking and smoking cessation
Encouragingly, results from the surveys indicate that two in 
three people who smoke wish to quit smoking. Odds ratios 
showed that factors associated with wishing to give up smoking 
included being under the age of 35 (1.6, 95% CI: 1.3–2.0), 
being married (1.3, 95% CI: 1.0–1.5), having a tertiary-level 
education (1.6, 95% CI: 1.1–2.4), and having an occupation of a 
non-routine/non-manual nature (1.3, 95% CI: 1.0–1.6). Almost 
one-half of those attempting to quit smoking used willpower 
alone; e-cigarettes and nicotine products were the most 
common methods among those who used smoking cessation 
aids. Similar to subjects who demonstrated an intention to 
give up smoking, successful quitters were also more likely to 
be young, educated to levels higher than primary level, and to 
have occupations of a non-routine/non-manual nature.
Conclusions
The authors concluded that the study provides a better 
understanding of the demographic factors independently 
associated with current smoking and that this might enable 
policymakers to adopt more targeted approaches to combat 
smoking. In addition, the study provides keen insights into 
the factors associated with quitting and remaining smoke-
free. The HSE will consider these results in the context of its 
State of tobacco control3 report to better understand the 
challenges and priorities for its Programme Plan 2018–2021.
Seán Millar
1 Department of Health (2013) Tobacco free Ireland: report of the 
Tobacco Policy Review Group. Dublin: Department of Health. 
https://www.drugsandalcohol.ie/20655/ 
2 Sheridan A, O’Farrell A, Evans D and Kavanagh P (2018) Adult 
smoking in Ireland: a special analysis of the Healthy Ireland 
Survey and The Irish Longitudinal Study on Ageing (TILDA). 
Dublin: Health Service Executive. https://www.drugsandalcohol.
ie/29203/
3 Health Service Executive (2018) The state of tobacco control in 
Ireland: HSE Tobacco Free Ireland Programme, 2018. Dublin: 
Health Service Executive. https://www.drugsandalcohol.ie/29348/
Another significant finding was the increasing proportion of 
cases reporting benzodiazepines as a main problem drug, 
which rose from 4.1% in 2010 to 9.7% in 2016. In addition, the 
proportion of cases treated for Z-drugs increased from 0.1% 
in 2010 to 1.1% in 2016.
The bulletin also reports on treated problem use of novel 
psychoactive substances (NPS). In this period, reported 
problem use of NPS as a main problem peaked in 2010, 
at 2.5% of all cases treated, and dropped to 0.4% of all 
cases treated in 2012. Since then, it has increased slightly 
to represent 0.8% of all cases treated in 2016. The majority 
of cases reported problem polydrug use (62.7%) over the 
period; however, the proportion has decreased from 66.7% 
in 2010 to 61.8% in 2016. Up to 2013, alcohol was the most 
common additional drug reported. 
Since 2014, benzodiazepines have become the most common 
additional drug reported by polydrug users.
The proportion of all cases treated who reported ever 
injecting remained relatively stable over the reporting period 
at around one-third of all cases. The proportion of new cases 
reporting ever injecting has decreased from 15.2% in 2010 to 
13.5% in 2016.
Ita Condron
1 Health Research Board (2018) Drug Treatment in Ireland  
NDTRS 2010 to 2016. Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/28986/ 
2 Data on ethnicity is taken from the 2016 Census from the Central 
Statistics Office (CSO). Further information is available online 
at: http://www.cso.ie/en/csolatestnews/presspages/2017/
census2016profile8-irishtravellersethnicityandreligion/ 
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perceived risk of smoking, perceived relative wealth, parental 
monitoring, maternal relationship, family structure, truancy, 
and peer smoking.
The study found that smoking prevalence among adolescents 
has dropped from 41% in 1995 to 13% in 2015. The prevalence 
was much higher among girls than boys in 1995 (44.9% vs 36.7, 
p<0.001). However, this gender gap was closed by 2015 (12.8% 
for females and 13.1% for males). Odds ratios from multivariate 
regression results demonstrated that peer smoking (18.9, 95% 
CI: 11.4–31.2), perceived access to cigarettes (1.4, 95% CI: 1.0–
2.1), perceived risks of smoking (1.9, 95% CI: 1.6–2.3), parental 
monitoring (3.2, 95% CI: 2.3–4.6), truancy (2.8, 95% CI: 1.9–4.1), 
maternal relationship (1.8, 95% CI: 1.4–2.4), perceived relative 
wealth (1.3, 95% CI: 1.0–1.7), and family structure (1.6, 95% 
CI: 1.1–2.2) were all significantly associated with adolescent 
smoking, with some of the factors having different effects for 
female and male students.
The authors concluded that Ireland has successfully 
achieved a considerable decrease in adolescent smoking 
from 1995 to 2015. Further improvement might be attained 
through strengthening enforcement of adolescent access to 
cigarettes and maintaining a high-intensity tobacco control 
media campaign. Parents could also contribute by enhancing 
monitoring.
Seán Millar
1 Department of Health (2013) Tobacco free Ireland: report of the 
Tobacco Policy Review Group. Dublin: Department of Health. 
https://www.drugsandalcohol.ie/20655/
2 Li S, Keogan S, Taylor K and Clancy L (2018) Decline of adolescent 
smoking in Ireland 1995–2015: trend analysis and associated 
factors. BMJ Open 8(4): e020708. https://www.drugsandalcohol.
ie/28946/ 
Decline in adolescent 
smoking in Ireland 
and associated 
factors
Policies designed to discourage adolescents from smoking 
have been at the forefront of tobacco prevention in recent 
years. In Ireland, the Tobacco free Ireland report of 2013 
stated that the protection of children must be prioritised with 
regard to initiatives outlined in the policy.1 A number of studies 
have been conducted regarding interventions for preventing 
adolescent smoking, including research evaluating policies 
to restrict access and raise awareness of risk. While some 
studies have examined perceptions of risk and its association 
with smoking, other studies have investigated correlates in 
the domestic and social sphere. These include associations 
with parental monitoring, relationships with parents, family 
structure, truancy from school, and peer smoking. 
A recent Irish study examined trends in smoking among Irish 
adolescents aged 15–16 years between 1995 and 2015 and 
factors associated with smoking behaviours.2 In this research, 
published in the journal BMJ Open, data were obtained from 
Irish waves of the European School Survey Project on Alcohol 
and Other Drugs (ESPAD). Multivariate logistic regression was 
performed to examine the factors associated with smoking 
behaviour. Smoking behaviour was defined as having smoked 
in the last 30 days. Independent variables examined included 
gender, survey years, perceived ease of access to cigarettes, 
Youth smoking in 
Ireland: findings from 
the Health Behaviour 
in School-aged 
Children survey 
Smoking is the leading cause of preventable death in Ireland.1 
As smoking typically initiates in youth, and given the highly 
addictive properties of nicotine, a high proportion will 
continue to smoke into adulthood with negative health 
consequences. The Health Service Executive (HSE) has 
recently published a report detailing findings from an 
Irish study that examined smoking behaviours in Ireland 
among children aged 9–18 years using data from the Health 
Behaviour in School-aged Children (HBSC) survey.2 Key 
findings from the report are discussed below.
Characteristics of young people who smoke  
in Ireland
It was found that 16% of children aged 9+ had smoked 
cigarettes in their lifetime, while 6% were classified as 
current smokers. Of these, 54% smoked every day, with 19% 
smoking at least once a week, and 27% smoking less often 
than once a week. The likelihood of being a current smoker 
increased with increasing age and lower socioeconomic 
status. There were no significant differences between boys 
and girls with regard to current smoking status.
Impact of smoking on health and wellbeing
After accounting for age, gender and social class, the study 
observed that children who smoked were almost 12 times more 
likely to have consumed alcohol and approximately 39 times 
more likely to have consumed cannabis in the last month; they 
were seven times more likely to have reported ever having 
had sex. Smokers were also three times more likely to have 
reported fair or poor health, to not being happy with life, and 
to disliking school. They were also more likely to have been in a 
fight in the last 12 months compared to non-smokers.
Impact of tobacco control measures
It was found that after controlling for age, gender and 
social class variables, smokers were less likely to have an 
understanding of the harms of smoking. Smokers were more 
likely to think that cigarette packs ‘looked cool’, to report 
that they had no smoking restrictions in their households, and 
twice as likely to report that they had no smoking restrictions 
in their family cars when compared to non-smokers. Children 
who smoked were also more likely to report that they found it 
easy to purchase cigarettes or that they found it easy to find 
someone to purchase cigarettes for them.
10
dr
ug
ne
t I
R
EL
AN
D
   
   
Is
su
e 
67
 |  
Au
tu
m
n 
20
18
Conclusions
The authors note that progress has been made in Ireland in 
preventing smoking initiation in children and young people 
and that the Government has made a welcome commitment 
to bring the tobacco epidemic to an end through its Tobacco 
Free Ireland programme.1 
However, they stress that a continued focus on initiation 
prevention will be critical to success. By identifying 
demographic factors independently associated with smoking 
behaviours, the current report will enable policymakers take 
a more focused approach to the problem.
Seán Millar
1 Department of Health (2013) Tobacco free Ireland: report of the 
Tobacco Policy Review Group. Dublin: Department of Health. 
https://www.drugsandalcohol.ie/20655/ 
2 Evans D, O’Farrell A, Sheridan A and Kavanagh P (2018) Youth 
smoking in Ireland: a special analysis of the Health Behaviour 
in School-aged Children (HBSC) study. Dublin: Health Service 
Executive. https://www.drugsandalcohol.ie/29202/
Youth smoking in Ireland continued
Forensic Science 
Ireland annual  
report 2017
Forensic Science Ireland (FSI) delivers a scientific service 
that supports the Irish criminal justice system by analysing 
samples that are gathered at crime scenes (e.g. DNA, 
chemistry, and drugs). Substances are submitted for analysis 
mainly by An Garda Síochána but also by the Garda Síochána 
Ombudsman Commission (GSOC), Customs and Excise, 
and the Military Police. In order to monitor the chain of 
custody, FSI has set procedures in place: substances are first 
accepted by FSI reception or case intake staff, then items 
are stored safely and securely, after which they are passed 
to a relevant scientist for analysis. In May 2018, FSI published 
its second annual report.1 What follows is an overview of the 
results and progress made by the FSI team in 2017. 
Results and progress of FSI team
Overall, 15,200 cases were submitted for analysis in 
2017, which was an increase of approximately 8% since 
2016 (n=14008). The demand for analysis went beyond 
the available resource capacity of FSI. Moreover, cases 
submitted varied in complexity and involved the prioritisation 
of several high-profile cases that involved drug seizures and 
gangland murders. These challenges resulted in backlogs, 
particularly for drugs submissions. 
Over 50% of cases (n=8456) received by FSI centred on 
substances that violated the Misuse of Drugs Acts 1977—2015. 
Figure 1 provides a summary of drug trends between 2007 
and 2017 for drugs that were submitted to FSI for analysis. 
Following a peak in overall drug submissions in 2009, 
submissions declined until 2012. Between 2012 and 2014 a 
slight increase was evident. Although a decreasing trajectory 
was shown between 2014 and 2016, between 2016 and 2017 
a slight increase was illustrated. Analyses of submissions 
for drugs that contravene Sections 15 and 17 of the Misuse 
of Drugs Acts increased between 2015 and 2016 and again 
between 2016 and 2017.
Figure 2 provides a summary of the number of cases 
analysed by drug type in 2017. The majority of cases 
submitted were for cannabis (39%), followed by powder 
(usually cocaine) and then heroin, 30% and 14%, 
respectively. 
Figure 3 compares drug submissions between 2016 and 2017, 
showing that submissions for cannabis and heroin decreased 
by 5% and 6%, respectively.1,2 In contrast, submissions 
for powder (usually cocaine) and tablets (usually MDMA) 
increased by 6% and 5%, respectively.
Figure 1: Trends in drug submissions to FSI from 2007 to 2017
Pe
rc
en
ta
ge
 %
Total
Males
Females
0
5
10
15
20
25
30
35
Paracetemol
27.8
21.7
32.0
Diazepam
11.5
14.5
9.4
Zopiclone
9.2
9.8
8.9
Alprazolam
7.8
7.7
7.8
Escitalopram
5.1
4.5
5.5
Zolpidem
4.6
3.8
5.2
Pregabalin
4.4
4.4
4.4
Venlafaxine
3.4
2.7
4.0
Flurazepam
3.4
3.4
3.4
Ibuprofen
6.6
4.8
7.9
Diclofenac
2.4
1.9
2.7
Illegal drugs
6.0
10.1
3.1
0
20
40
60
80
100
120
140
160
180
0
20 000
40 000
60 000
80 000
100 000
120 000
140 000
160 000
180 000
2007 2009 201620152008 201720142013201220112010
Total Section 15 (including Section 17) 
Source: Forensic Science Ireland annual report 2017, Figure 2, p. 14
11
Issue 67 | Autum
n 20
18
     drugnet IR
ELAN
D
      
Forensic Science Ireland continued
Figure 2: Different types of drug analysis carried out by the FSI 
Drugs Section 
 
 
Source: Forensic Science Ireland annual report 2017, Figure 3, p. 15 
New substances
The emergence of new substances creates another challenge 
for FSI, as no reference standards are available to which they 
can be compared. In 2017, some 15 new substances were 
identified in Ireland. 
Court appearances and defence visits
In 2017, FSI employees gave evidence in court in 104 cases, 
covering drugs, sexual assault, armed robbery, burglary, 
explosives, and firearms. In addition, defence scientists 
visited FSI on 49 occasions to re-examine evidence, for 
example, DNA and drugs seizures. 
Presumptive testing
Presumptive drug testing (PDT), which was introduced in 
2011, enables Gardaí trained by FSI to carry out tests using 
commercially available chemical test kits to determine if 
suspect materials are controlled drugs (e.g. cannabis herb 
or resin; cocaine). The rationale behind this approach was 
to reduce the frequency of Section 3 drug cases being 
submitted to FSI so that they could target their resources 
on Section 15 (dealing) and Section 17 (cultivation) cases. 
However, 1,700 of 4,282 Section 3 cases submitted to 
FSI were indeed cannabis cases, which could have been 
assessed by PDT. FSI continues to liaise with An Garda 
Síochána to promote the use of PDT. 
DNA database
Another useful resource implemented by FSI in 2015 was 
the DNA database. This database allows Gardaí to make 
investigative links between people and unsolved crimes. 
Cases can be linked individually or in clusters. In 2017, some 
601 hits occurred and which assisted 913 cases. There were 
two types of hits: linking crime scene samples and linking 
persons to crime stains.
Linking crime scene samples
Crime scene samples linked to other crime scene samples 
were reported 66 times in 2017 and resulted in 138 
investigative links, two of which were related to drugs.
Linking persons to crime stains
Person-to-stain matches were reported 535 times, which 
assisted 775 cases, of which 28 were related to drugs.
Conclusion
The annual report illustrated that the FSI service contributed 
substantially to assisting law enforcement agencies in the 
fight against crime. The demand for analyses far exceeded 
FSI resource capacity and this gap is expected to further 
increase in 2018. However, a new workforce plan aims to 
target this issue, enabling FSI to improve the services it 
provides, widen its capabilities and personnel.
Ciara H Guiney
1 Forensic Science Ireland (2018) Forensic Science Ireland  
annual report 2017. Dublin: Forensic Science Ireland.  
https://www.drugsandalcohol.ie/29055/
2 Forensic Science Ireland (2017) Forensic Science Ireland  
annual report 2016. Dublin: Forensic Science Ireland.  
https://www.drugsandalcohol.ie/27308/
Figure 3: Comparison of different types of drug analysis carried out by the FSI Drugs Section by year
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18 Irish Prison Service 
and Probation 
Service strategic 
plan 2018–2010
On 25 June 2018, the Minister for Justice and Equality, 
Charlie Flanagan TD, launched the joint Irish Prison Service 
(IPS) and Probation Service (PS) strategic plan for 2018–
2020.1 This is the third joint strategy of these agencies.  
It includes the following actions: 
• Improve sentence management
• Maximise joint working between IPS and PS
• Develop responses for female offenders
• Enhance engagement with victims of crime
• Develop innovative responses for specific groups of 
offenders
• Enhance offender employability
• Engage with service users
• Promote research and evaluation
• Improve provision of drug and alcohol services
Improve sentence management
With the aim of decreasing recidivism, programmes will 
continue to be established and delivered in prison. It 
is hoped that this will increase offender engagement, 
resettlement and reintegration into society, and stability on 
release from prison leading to less re-offending and safer 
communities.
Maximise joint working between IPS and PS
To enhance collaborative working between agencies, 
improvements to systems will continue. This will involve the 
establishment of service level agreements identifying the 
role of the PS in sentence management and reintegration, 
and improvements on how data will be captured. Joint 
development of interventions will continue along with joint 
training to promote collaboration and shared learning. In 
addition, the IPS psychology service will assign a psychologist 
to PS headquarters to consult on cases, programme 
development, assessment, and to assist in training. 
Develop responses for female offenders
The IPS and PS intend to build on current gender-informed 
approaches, broaden opportunities, and target through-care 
and resettlement into society. This work will be informed by 
joint research and best evidence-based practice on female 
offending and custodial trends. Interventions will aim to 
increase recovery and provide education and training. To help 
women and children affected by domestic violence and abuse, 
perpetrators of these crimes will continue to be targeted.
Enhance engagement with victims of crime
In line with current legislative requirements for victims of 
crime,2,3 the IPS and PS will develop and apply procedures on 
engaging with victims of crime. Existing information and how 
it is accessed will be reviewed. The provision and response 
to restorative justice intervention requests will follow existing 
practices. Written submissions to the Parole Board by victims 
will also be facilitated. Further victim engagement will be 
informed by evaluations of existing practices and procedures. 
Develop innovative responses for specific 
groups of offenders
Drawing on evidence-based best practice, the IPS and PS will 
collaborate to increase engagement with specific groups of 
offenders, such as sexual and violent offenders, young adults 
aged 18–24 years, older adults, and the Traveller community. 
Several actions will be taken, for example: 
• The Sex Offender Risk Assessment and Management 
(SORAM) will be fully implemented in prisons.
• The Building Better Lives (BBL) programme for sexual 
violence will be established in the Midlands Prison and 
Arbour Hill Prison.
• Young adults sentence planning and community 
reintegration will continue to progress.
• Work will continue to increase engagement and 
interventions with offenders who are mentally unwell, 
members of the Traveller community, and perpetrators 
of domestic violence.
Enhance offender employability
The IPS and PS will collaborate to maintain and increase 
employment opportunities for ex-offenders. For example, 
the social enterprise strategy, A new way forward,4 will be 
implemented. In addition, greater emphasis will be placed 
on employment outcomes for GATE (Gaining Access to 
Training, Education and Employment) and Linkage services 
provided by the Irish Association for the Social Integration 
of Offenders. The IPS and PS will also work with Intreo 
services of the Department of Employment Affairs and Social 
Protection to establish joint procedures to make certain the 
move from training to employment goes smoothly. 
Engage with service users
The intention is to enhance service delivery by working 
with service users and organisations to make peer-led 
opportunities available. For example, a joint service level 
agreement will be established between the IPS/PS and the 
Irish Red Cross to increase community-based health and first 
aid (CBHFA) programmes in prisons and the community and 
widen the curriculum to help reduce recidivism. Rehabilitation 
programmes will also be facilitated by the IPS and PS for female 
ex-offenders that have participated in the BRIO programme. 
Promote research and evaluation
To ensure that the work undertaken by the IPS and PS 
is informed by evidence-based practice, research and 
evaluation will be encouraged in several areas; for example, 
working with female offenders, life-sentenced prisoners, 
provision of rehabilitative interventions, desistence from 
offending, and the impact of the CBHFA programme. 
Research in these areas will increase knowledge and enhance 
opportunities to stop and prevent crime. 
Improve provision of drug and alcohol services
The IPS and PS will jointly increase drug and alcohol service 
provision in prisons and the community. Their actions will be 
guided by the recommendations of the Review of drug and 
alcohol treatment and the current national drugs and alcohol 
strategy, Reducing harm, supporting recovery.5,6
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2 Criminal Justice (Victims of Crime) Act 2017. Available online at: 
http://www.irishstatutebook.ie/eli/2017/act/28/enacted/en/html 
3 European Commission (2012) Directive 2012/29/EU. Available 
online at: https://ec.europa.eu/anti-trafficking/legislation-and-
case-law-eu-legislation-criminal-law/directive-201229eu_en 
4 Irish Prison Service and Probation Service (2017) ‘A new way 
forward’: social enterprise strategy 2017–2019. Dublin: Department 
of Justice and Equality. https://www.drugsandalcohol.ie/27287/
5 Clarke A and Eustace A (2016) Review of drug and alcohol 
treatment services for adult offenders in prison and in the 
community. Dublin: Probation Service and Irish Prison Service. 
https://www.drugsandalcohol.ie/26569/ 
6 Department of Health (2017) Reducing harm, supporting 
recovery: a health-led response to drug and alcohol use  
in Ireland 2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/ 
7 Department of Justice and Equality (2018) Minister Flanagan 
publishes the Probation Service Strategy 2018–2020 ‘One Vision, 
One Team, One Standard’, the third Probation Service and Irish 
Prisons Service joint strategic plan 2018–2020 and the Probation 
Service and Irish Prison Service annual reports 2017. Dublin: 
Department of Justice and Equality. Available online at:  
https://www.justice.ie/en/JELR/Pages/PR18000207 
Conclusion
This strategy was welcomed by the Minister for Justice and 
Equality, who stated that:
This is an excellent example of agencies working 
together. The Strategic Objective of the Plan is to have 
a multi-agency approach to offender management and 
rehabilitation from pre to post imprisonment in order to 
reduce re-offending and improve prisoner outcomes.7
An integrated approach is viewed by the minister as an 
essential component for the effective reintegration of 
offenders into the community and society.7
Ciara H Guiney
1 Irish Prison Service and Probation Service (2018) Irish Prison 
Service & Probation Service: strategic plan 2018–2020.  
Dublin: Irish Prison Service and Probation Service.  
https://www.drugsandalcohol.ie/29241/ 
Irish Prison Service and  
Probation Service continued
Prevalence of major 
mental illness, 
substance misuse 
and homelessness 
among Irish prisoners
There are 12 institutions in the Irish prison system, 
comprising 10 traditional ‘closed’ institutions and two 
open centres, which operate with minimal internal and 
perimeter security. The majority of female prisoners are 
accommodated in the purpose-built Dóchas Centre adjacent 
to Mountjoy Prison in Dublin, while the remainder are located 
in a separate part of Limerick Prison.1 Between 1970 and 
2011, the Irish prison population increased by 400%.2 Mental 
disorders, substance misuse and homelessness have been 
highlighted as key areas of need among Irish prisoners. 
However, although the prevalence of these vulnerabilities 
have been studied by health services and governmental 
or non-governmental organisations, they have not been 
systematically reviewed. 
Recent Irish research aimed to systematically review studies 
from Irish prisons that estimate the prevalence of major 
mental illness, alcohol/substance misuse and homelessness 
at the time of committal.2 In this study, published in the Irish 
Journal of Psychological Medicine, healthcare databases 
were searched for studies quantifying the point prevalence 
for each outcome of interest. Searches were augmented by 
scanning bibliographies and searches of governmental and 
non-governmental websites. Proportional meta-analyses 
were completed for each outcome. The major findings with 
regard to these outcomes are discussed below.
Psychotic and major affective disorders
Eight studies with a total sample size of 28,012 prisoners 
reported data on psychotic disorders. Using a random effects 
model, the pooled percentage of Irish prisoners suffering 
from a psychotic disorder was 3.6% (95% CI: 3.0–4.2%). The 
prevalence in male samples was estimated at 3.8%. Only two 
studies evaluated prevalence in purely female samples, and 
estimates for females were 3.9%. Estimates of prevalence in 
purely remand samples could be extracted from four studies 
and were 3.9% (see Figure 1).
Seven studies with a total sample size of 7,928 prisoners 
reported on affective disorders. The pooled percentage of 
prisoners suffering from an affective disorder was 4.3% (95% 
CI: 2.1–7.1%). Prevalence estimates from male samples were 
2.3% and from female samples were 9.1%. Estimates of the 
prevalence of affective disorders in purely remand samples 
could only be extracted from two studies and were 2.1%  
(see Figure 2).
Alcohol and substance use disorders
Six studies with a total sample size of 1,659 prisoners reported 
on alcohol or substance use disorders. The pooled percentage 
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Figure 1: Percentage of Irish prisoners with a psychotic disorder 
at time of committal
Source: Gulati et al. (2018)2
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of prisoners suffering from an alcohol disorder across the six 
studies was 28.3% (95% CI: 19.9–37.4%) (see Figure 3). The 
pooled percentage of prisoners reporting a substance use 
disorder was 50.9% (95% CI: 37.6–64.2%) (see Figure 4).
The prevalence estimates for male only samples were 
37.1% and 51% for alcohol and substance use disorders, 
respectively. Two studies evaluated prevalence in purely 
female samples and estimates for females were 17.2% for 
alcohol use disorder and 62.6% for substance use disorder. 
Prevalence estimates for purely remand samples could be 
extracted from only one study and were 34.5% and 53% for 
alcohol and substance use disorders, respectively.
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Figure 2: Percentage of Irish prisoners with a major affective 
disorder at time of committal
Source: Gulati et al. (2018)2
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Figure 3: Percentage of Irish prisoners with an alcohol use 
disorder at time of committal
Source: Gulati et al. (2018)2
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Figure 4: Percentage of Irish prisoners with a substance use 
disorder at time of committal
Source: Gulati et al. (2018)2
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Figure 5: Percentage of Irish prisoners who were homeless at 
time of committal
Source: Gulati et al. (2018)2
Irish prisoners continued Homeless on committal
Five studies with a total sample size of 1,523 prisoners 
reported on prisoners who were homeless at time of 
committal. The pooled percentage of homelessness from 
a random effects model was 17.4% (95% CI: 8.7–28.4%). 
Prevalence estimates in purely male samples were 8.2%. 
Only one study evaluated prevalence in a purely female 
sample and the estimate for females was 18.8%. Prevalence 
estimates from remand samples could be extracted from 
two studies and were 23.2% (see Figure 5).
Conclusions
The authors concluded that the study showed prevalence 
estimates of psychotic illness and substance abuse among 
Irish prisoners that are in keeping with international 
estimates of morbidity in prisons, while those for affective 
disorders are lower. The prevalence of homelessness on 
committal to Irish prisons is higher than some international 
estimates. 
As rates of psychoses, alcohol/substance misuse and 
homelessness among Irish prisoners are significantly higher 
than in the general population, the study highlights the 
need for improved screening for affective disorders, the 
development of diversion services, and the consideration of 
integrated treatment plans for addressing psychiatric and 
psychosocial need. In particular, the authors suggest that 
homeless individuals with mental illness are unlikely to seek 
help or treatment. 
In addition, subjects who have an active substance 
misuse disorder are often excluded from temporary 
accommodation, which may result in further social decline 
and increased risk of imprisonment.
Seán Millar
1 Irish Prison Service (2018) Irish Prison Service annual  
report 2017. Longford: Irish Prison Service.  
https://www.drugsandalcohol.ie/29244/ 
2 Gulati G, Keating N, O’Neill A, Delaunois I, Meagher D and Dunne 
CP (2018) The prevalence of major mental illness, substance misuse 
and homelessness in Irish prisoners: systematic review and meta-
analyses. Ir J Psychol Med: 1–11: doi:10.1017/ipm.2018.15.  
https://www.drugsandalcohol.ie/29009/ 
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Hospital 
presentations and 
preceding factors of 
drug overdose among 
adolescents
Suicide is one of the major causes of death in many 
populations, particularly adolescents, and poisoning or drug 
overdose (OD) is the leading method of attempted suicide. 
Public health interventions aim to reduce the morbidity 
and mortality of self-poisoning by limiting the availability 
of potentially toxic medications to at-risk populations. 
An understanding of the preceding factors and potential 
triggers of self-poisoning and drug overdose may aid in the 
development of specific intervention strategies. 
Recent Irish research aimed to highlight the pattern of 
presentations and preceding factors of OD in an adolescent 
population.1 In this study, published in the Irish Medical 
Journal, the authors retrospectively evaluated the data of 
85 adolescents (81.2% female) presenting to a large regional 
hospital in Ireland with OD over a three-year period. Data 
were retrieved from the Hospital Inpatient Enquiry (HIPE) 
system, and included information on patients’ demographics, 
preceding factors, and drugs used in OD.
Results
The median age at presentation was 15.83 years. The median 
time from event to hospital presentation was 2.6 hours, with 
the mean length of hospital stay being 2.24 days. Thirty-eight 
(44.7%) adolescents had a history of deliberate non-drug-
related self-harm, while 14.1% (n=12) were previously seen 
for deliberate self-poisoning/OD. Among factors associated 
with OD, the following were noted:
• Depression was the most common mental health problem 
associated with OD. 
• Other preceding factors included unstable family 
dynamics, family history of mental illness, social 
problems, and romantic break-ups. 
• Certain factors had gender predilection: substance abuse 
and conduct disorder were more common among males.
The drugs implicated in adolescent OD presentations are 
shown in Figure 1. The most common agents of overdose 
were analgesics (n=83), with acetaminophen being the 
most commonly used analgesic. Other drugs used in OD 
cases included antidepressants, antipsychotics, antibiotics, 
and antihistamines. Forty-six (54.1%) cases presented with 
polypharmacy overdose. Three patients (3.5%) inhaled a 
kitchen aerosol spray, while concomitant alcohol (vodka) and 
drug overdose was documented in 17.6% (15/85) of cases.
Conclusions
The authors suggest that the number of OD patients in this 
study probably represent only a small proportion of OD 
cases among adolescents and that it is likely that substantial 
numbers of self-poisoning occur in the community. Gender 
differences should be considered in the assessment, 
prevention, and management of future self-harm or suicides 
by community policymakers and clinicians.
Seán Millar
1 Maduemem K, Adedokun C and Umana E (2018) Presentations 
and preceding factors of drug overdose amongst adolescents 
admitted to a large regional hospital. Ir Med J, 111(4): 731. https://
www.drugsandalcohol.ie/28870/ 
 
 
 
Figure 1: Number of drugs implicated in OD among adolescents 
 
 
 
Source: Maduemem et al. (2018)1
SSRI: Selective serotin reuptake inhibitor
AED: Anti-epilepsy drug
Others: Multivitamins; iron; Lyrica; Eltroxin; oral contraceptive pills; valerian; pantoprazole; furosemide; statins; ecstasy; bleach; kitchen spray
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18 (OST) is available in most parts of the country. Incidence of BBV 
among PWID has been declining in recent years. 
With good uptake of BBV testing and the use of highly effective 
direct-acting antiviral drugs, it is possible to anticipate the 
elimination of hepatitis C in Ireland. Nevertheless, statutory 
notifications, studies on OST settings and in prison indicate a 
high prevelance of this disease in Ireland among PWID. Further, 
a small number of those entering treatment for cocaine use 
are injecting and 12% of those entering treatment in 2015 had 
injected at some time in the past. This cohort of PWID, along 
with those using new psychoactive substances, performance 
enhancing drugs, or chemsex drugs, are less likely to self-
identify as problem drug users or avail of BBV testing, harm 
reduction and drug treatment services.
The report identifies gaps in knowledge and opportunities 
for improvements in the way information is collected and 
recorded. Routine monitoring would be much improved 
by extending electronic record-keeping of treatment 
information and laboratory results to facilitate easy 
extraction of the data for reporting. There are extensive 
and heavily used needle exchange services. If these services 
could be expanded to include BBV screening and onward 
referral, it would then be possible to collect data on the 
users of these services most at risk from BBV. 
Brian Galvin
1 Health Protection Surveillance Centre (2018) Drug-related 
bloodborne viruses in Ireland. Dublin: Health Protection 
Surveillance Centre. http://www.drugsandalcohol.ie/29685/ 
2 Hay G, Jaddoa A, Oyston J, Webster J, Van Hout MC and Rael dos 
Santos A (2017) Estimating the prevalence of problematic  
opiate use in Ireland using indirect statistical methods.  
Dublin: National Advisory Committee on Drugs and Alcohol.  
http://www.drugsandalcohol.ie/27233/ 
3 Health Research Board (2018) Drug treatment in Ireland  
(NDTRS) 2010–2016. Dublin: Health Research Board.  
http://www.drugsandalcohol.ie/28986
RESPONSES 
New report on drug-
related bloodborne 
viruses in Ireland
People who inject drugs (PWID) are at high risk of contracting 
bloodborne viruses (BBV) and comprise three-quarters of 
diagnosed cases of hepatitis C in Ireland. Surveillance of 
drug use and drug-related BBV is essential for monitoring 
the impact of prevention and harm reduction programmes. 
The Health Protection Surveillance Centre (HPSC) recently 
published a comprehensive summary of drug-related BBV in 
Ireland.1 The report was compiled by a collaborative group 
comprising representatives from several health agencies, 
doctors, and others active in harm reduction and drug 
treatment work in Ireland. The final report was authored by 
HPSC staff.
The aim of this report is to summarise what is currently 
known about drug-related BBV in Ireland. The report focuses 
on hepatitis C, HIV, and hepatitis B and begins by outlining 
problem drug use associated with an increased risk of these 
infections. Recent opioid prevalence data show that the 
numbers of those using opioids, mainly heroin, have not 
changed substantially between 2006 and 2014, but that a 
much higher proportion of those who are using these drugs 
are aged between 35 and 64 years.2 Incidence of opioid use 
is declining and National Drug Treatment Reporting System 
(NDTRS) data indicate a steady decline in new entrants to 
treatment who reported opioids as their primary problem drug 
between 2009 and 2016, and a decrease in the proportion who 
inject.3 Treatment coverage for people who use opioids is high 
by international standards and opioid substitution treatment 
Integrated hepatitis 
C care for people 
who inject drugs
Hepatitis C virus (HCV) infection is a major cause of chronic 
liver disease and death. Drug use remains the significant 
cause of new infections in the European Union (EU), with 
estimates of HCV antibody prevalence among people who 
inject drugs (PWID) ranging from 5% to 90% in 29 European 
countries.1 In the Republic of Ireland and the EU, primary 
care is a key area to focus efforts to enhance HCV diagnosis 
and treatment among PWID. Recently developed HCV direct-
acting antiviral drugs are well tolerated and delivered for 
shorter courses (8–12 weeks), with trials reporting more than 
90% cure rates among PWID.2 However, despite these highly 
effective treatments, many people at risk are unaware of 
their infection and obstacles may limit access to HCV care, 
resulting in many patients not being treated. 
A recent paper, published in the journal JMIR Research 
Protocols, outlines the protocol for a study which will 
examine integrated HCV care for PWID.3 The research will 
be a prospective, non-randomised, pre–post intervention 
feasibility study, and will be conducted in opioid substitution 
treatment (OST)-prescribing general practices from three 
sites across the HepCare Europe consortium (Dublin, London 
and Seville). A total of 24 OST-prescribing general practices 
have been recruited from the professional networks and 
databases of members of the research consortium. Patients 
were eligible for inclusion in the study if aged ≥18 years, on 
OST, and had attended the practice for any reason during the 
recruitment period. Baseline data on HCV care processes 
and outcomes were extracted from the clinical records of 
the participating patients.
Intervention and outcomes
The aim of the intervention is to enhance identification and 
linkage to HCV care and treatment among patients attending 
primary care for OST. It includes the following:
• Outreach of an HCV-trained liaison nurse into general 
practices
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• The experience and evaluation of the intervention among 
key informants (clinicians and patients)
• The number of patients attending general practice for 
OST post-intervention for follow-up testing
• Evaluation of the feasibility and possible efficacy of the 
intervention by comparing pre–post intervention data
• Evaluation of the cost-effectiveness of the intervention
• Comparison of clinician knowledge, attitudes and 
practice pre–post intervention.
Conclusions
The authors of this research protocol state that the study is 
ongoing and has the potential to make an important impact 
on patient care and provide high-quality evidence to help 
clinicians make important decisions on HCV testing and 
onward referral. As a substantial proportion of HCV-positive 
patients on OST in general practice are not engaged with 
specialist hospital services, but qualify for direct-acting 
antiviral drugs treatment, the study has the potential to 
reduce HCV-related morbidity and mortality.
 
Seán Millar 
1 Lazarus JV, Sperle I, Maticic M and Wiessing L (2014) A 
systematic review of hepatitis C virus treatment uptake among 
people who inject drugs in the European region. BMC Infect Dis, 
14 (Suppl 6): S16. https://www.drugsandalcohol.ie/22756/ 
2 Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, et al. 
(C-EDGE CO-STAR Study Group) (2016) Elbasvir-Grazoprevir to 
treat hepatitis C virus infection in persons receiving opioid agonist 
therapy: a randomized trial. Ann Intern Med, 165(9): 625-34.
3 McCombe G, Swan D, O’Connor E, Avramovic G, Vickerman P, 
Ward Z, et al. (2018) Integrated hepatitis C care for people who 
inject drugs (Heplink): protocol for a feasibility study in primary 
care. JMIR Res Protoc, 7(6): e149. https://www.drugsandalcohol.
ie/29155/ 
• In-practice education for clinicians regarding 
developments in diagnosis and treatment of HCV
• Enhanced access of patients to community-based 
evaluation of HCV disease, including novel approaches to 
diagnosis
• A researcher-facilitated practice audit of HCV care 
processes and feedback to general practices.
 
Primary outcomes measures of the study will include the 
proportion of participants who have been screened for HCV 
and the proportion of HCV antibody-positive patients who 
commenced/completed antiviral therapy and who achieved 
a sustained virologic response. Secondary outcomes will 
include the following: 
• The proportion of those screened who tested HCV 
antibody positive
• The proportion of HCV-positive patients who have been 
assessed using novel approaches
• The proportion of HCV-positive patients who have been 
referred to specialist hepatology or infectious disease 
services
• The proportion of HCV-positive patients who have 
attended specialist hepatology or infectious disease 
services
• The proportion of HCV-positive patients who received an 
alcohol screening brief intervention
• The proportion of participants tested for anti-HIV 
antibody, anti-HBc (hepatitis B core) antibody, or 
hepatitis B surface antigen (HBsAg)
• The proportion of participants immunised against 
hepatitis B/A virus
Hepatitis C care continued
High uptake of 
sterile crack pipes in 
response to surge in 
cocaine use in Dublin
An article published in July 2018 by The Journal.ie explained 
that needle exchange services in Dublin had noted a strong 
uptake of clean crack pipes by service users in response to 
a surge in the availability and consumption of crack cocaine 
in 2018.1
Merchants Quay Ireland (MQI), which offers a range of 
services for people who are homeless and experiencing 
addiction issues, began providing clean crack pipes from 
its centre on the south quays on 13 July; 69 pipes were 
dispensed in the scheme’s first week of operation. The Ana 
Liffey Drug Project (ALDP), which runs an outreach needle 
and syringe programme based in Middle Abbey Street, began 
handing out reusable crack pipes in April 2017. Since then, 
287 pipes have been distributed. Of these, almost one-half 
(128) were handed out between March and July 2018. ALDP 
noted that while most of their clients smoke crack, staff 
have recently been engaging with a cohort of people who are 
neck-injecting the drug, an activity which ALDP describes as 
a ‘very risky activity’.  
The use of cocaine has now returned to Celtic Tiger levels in 
Ireland and the Health Service Executive (HSE) has recently 
launched a new harm reduction campaign, in conjunction 
with ALDP, to provide information and advice to users about 
both cocaine powder and crack cocaine.2 Tony Geoghegan, 
CEO of MQI, noted that individuals they deal with are 
primarily street drug users, rough sleepers, and people 
who are homeless, and that these would not necessarily be 
archetypal users, as cocaine use is more widespread across 
society. Nevertheless, he stated that it is important to 
address drug use in this cohort, as cocaine and crack have 
the propensity for harm very quickly.
Seán Millar
1 Hennessy M and Brophy D (2018) High uptake of sterile crack 
pipes in response to surge in use of drug in Dublin, The Journal.
ie, 22 July. Available online at: http://www.thejournal.ie/crack-
dublin-4138921-Jul2018/ 
2 Health Service Executive (2018) Cocaine – reduce the harms. 
Dublin: Health Service Executive. 2018. Available online at:  
https://www.hse.ie/eng/services/news/media/pressrel/cocaine-
reduce-the-harms.html
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of the problem. SAFE provides harm reduction services to 
those who are using crack cocaine and heroin. Over the 10 
months leading up to the launch, it has built an effective, 
coordinated response to the problems identified by the 
steering group and provided support to a very marginalised 
group of people. 
Many of the people whom SAFE supports present with 
specific and complex needs and are often hard to reach. 
SAFE has developed a vital service that is safe, supportive 
and empathetic to the service user's individual needs. 
The effectiveness of the campaign is due to the close 
partnership between Irish Rail, An Garda Síochána (AGS), 
CASP, Clondalkin Tus Nua, SWRDTF, South Dublin County 
Council, ALDP, and the HSE Addiction Services Outreach 
Team. The success of the initiative is underpinned by 
collobaration between all of these agencies and the local 
drugs task force. It is an excellent example of a coordinated, 
targeted, and effective harm reduction campaign. 
Brian Galvin
SAFE campaign 
launched in 
Clondalkin
SAFE (Support, Advice, Free Exchange, Empathy) is a new harm 
reduction awareness campaign based in Clondalkin, Dublin. 
It is the result of a collaborative effort between Clondalkin 
Drug and Alcohol Task Force (CDATF), An Garda Síochána, 
Irish Rail and local drug services, Tus Nua and Clondalkin 
Addiction Support Programme (CASP). Ms Frances Fitzgerald 
TD launched the campaign on 1 October 2018 at an event 
attended by all the stakeholders involved in the campaign and 
local community groups. SAFE began as a response to the 
increasingly visible use of drugs, antisocial behaviour, and drug 
litter in the Clondalkin area. A steering group was established 
to coordinate a harm reduction initiative with a focus on 
providing support to very vulnerable people, many of whom 
had travelled to the area to obtain or use drugs.
The steering group was particularly concerned with activity 
around the local railway station and there was a need to 
coordinate the response with organisations outside of the 
Clondalkin area. The involvement of the South Western 
Regional Drugs and Alcohol Task Force (SWRDTF) and the 
Ana Liffey Drug Project (ALDP) in the campaign provided the 
continuum of support needed to deal with the mobile nature 
Attending the launch of the SAFE Campaign on 1 October 2018 in Clondalkin (from L-R):  
Inspector Liam Casey (AGS), Brian Downes (assistant station manager with Irish Rail), Sharon Harty 
(team leader with CASP), Emma Fox (treatment and rehabilitation officer with CDATF), Paul Grace 
(outreach worker with Clondalkin Tus Nua), Cllr Mark Ward (mayor of South Dublin County Council and 
task force board member), Jennifer Clancy (coordinator with CDATF), Ms Frances Fitzgerald TD, Leeann 
McDonagh (AGS), Tara Deacy (prevention officer with CDATF), Paul Stanton (area manager with Irish 
Rail), and Jane Cregan (communications officer with Irish Rail)
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had endured the problem behaviour of their family member 
for years, only seeking help when the situation became 
chaotic or unmanageable. Prior to seeking help for their 
family member, participants had not considered that they 
might benefit from support in their own right. Participants 
also lacked awareness of available supports and of the kinds 
of support that might best suit their needs. 
Participants learned about available supports through family 
members, colleagues and social services, or were referred 
from peer-led support to counselling and other support 
services. All participants had at some point accessed 
either a drug education programme, family support, a 
residential treatment centre or (most commonly) addiction 
counselling. Other supports included Al-Anon, parent 
education initiatives, general counselling, yoga, church, 
and mindfulness. Informal supports, where accessed, were 
created through contact with formal supports. Semi-
formal supports were more common and included general 
practitioners, Gardaí, teachers, and work colleagues. Most 
participants accessed more than one type of support for 
reasons including availability, preference, location, and 
logistics. All had sought informal or semi-formal support 
before coming into contact with formal supports. 
For participants, perceived stigma, shame, embarrassment 
and concerns around confidentiality and anonymity were 
significant barriers to accessing support and to engaging with 
support once accessed. Additional barriers were an absence 
of local supports, long distance travel, childcare, and poor 
awareness of relevant issues among related professionals. 
A lack of interagency cooperation was further cited as a 
barrier. 
Participants were positive about the formal support they 
received, but felt that both semi-formal and informal 
supports (including family) sometimes lacked relevant 
knowledge, empathy, and understanding. The benefits of 
accessing support included emotional support, better 
coping, enhanced wellbeing, and feeling less isolated and 
more informed. Participants also described increased self-
esteem and confidence from family support and counselling. 
To overcome barriers to accessing support, participants 
suggested education and awareness programmes in schools 
and public spaces, as well as increasing the visibility of 
supports through various media. Participants further 
suggested better integration of formal supports and the 
upskilling of professionals providing semi-formal support. 
Implications
The authors suggest that full implementation of the existing 
National Drugs Rehabilitation Framework and Protocols7,8 
for coordination and integrated working among drug and 
alcohol family support services would address many of the 
barriers identified by participants. They propose that better 
coordination of local services is needed to ensure affected 
family members can easily access support appropriate to 
their needs. They further propose that service provision 
would be enhanced though additional investment, wider 
availability of family support, and increased capacity within 
the sector to work with affected family members. The 
authors highlight the role of policymakers and national 
organisations in service development, promotion, education, 
awareness, and training of the workforce. 
The help-seeking 
behaviours of family 
members affected 
by substance-use 
disorders
Research published in April 2018 in Child Care in Practice 
explored in depth the help-seeking behaviours of those 
affected by substance-use disorder among family members, 
with a view to informing the design and delivery of support 
services for affected persons.1 The study focused on 
affected family members’ use and assessment of available 
supports, barriers encountered in accessing supports, and 
recommendations for overcoming these barriers. 
Background
There is an increasing awareness that persons affected by 
the substance-use behaviours of their family members are 
in need of support in their own right. Support can enable 
affected family members to learn ways of coping with the 
emotional, psychological, and physical stress experienced 
as a result of problem substance use in their family. Formal 
support for affected family members is provided through 
community, voluntary, and statutory addiction services 
and through specialised family support and family-based 
programmes. Affected family members may also access 
support informally through family, friends, and community, 
and semi-formally through professionals in other sectors. 
Research links the adequacy of the support received with 
positive outcomes for families.2,3 However, research suggests 
that affected family members tend to put their family’s 
wellbeing before their own and to seek help for their family 
member and not themselves.4,5 Additionally, affected family 
members may avoid seeking help because of the stigma 
attached to persons who have issues with problem substance 
use and to their associates.6 
Method
Interviews were conducted with 10 participants (nine females 
and one male) who were recruited through Drug and Alcohol 
Task Forces and statutory drug services across urban and 
rural locations. Participants were persons with at least one 
family member with a history of substance-use disorder 
for a minimum of five years and who had sought support 
from at least one formal drug/alcohol service/programme. 
Participants had varying relationships to their family 
members (parents, partner, sibling, and adult child) and the 
circumstances of their family members ranged from active 
substance use, to in recovery, to deceased. 
Findings 
Participants reported multiple negative consequences of the 
substance use of their family member, including overdose, 
attempted suicide, bereavement, imprisonment, and drug-
related intimidation and violence. Participants experienced 
stress and strain and feelings such as guilt, shame, fear, 
embarrassment, and a sense of failure. Typically, participants 
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18 2 Gardner R (2006) Safeguarding children through supporting 
families. In P Dolan, J Canavan and J Pinkerton (eds), Family 
support as reflective practice (pp. 103–117). London: Jessica 
Kingsley. 
3 Sheppard M (2009) Social support use as a parental coping 
strategy: its impact on outcome of child and parenting problems – 
a six-month follow-up. Br J Soc Work, 39(8): 1427–46.
4 Barnard M (2007) Drug addiction and families. London: Jessica 
Kingsley. 
5 Salter G and Clark D (2004) The impact of substance misuse 
on the family: a grounded theory analysis of the experiences 
of parents. Swansea: WIRED and Department of Psychology, 
University of Wales. 
6 Keyes KM, Hatzenbuehler ML, McLaughlin KA, Link B, Olfson M, 
Grant BF, et al. (2010). Stigma and treatment for alcohol disorders 
in the United States. Am J Epidemiol, 172(12): 1364–72.
7 National Drugs Rehabilitation Implementation Committee (2010) 
National Drugs Rehabilitation Framework document. Dublin: 
Health Service Executive. https://www.drugsandalcohol.ie/13502/ 
8 National Drugs Rehabilitation Implementation Committee (2011) 
National protocols and common assessment guidelines to 
accompany the National Drugs Rehabilitation Framework. Dublin: 
Health Service Executive. https://www.drugsandalcohol.ie/16717/ 
Conclusion
Persons affected by problem substance use in their family 
experience considerable stress and strain and are often 
isolated and unaware of supports available to them. The 
study has highlighted the support needs of this group, as 
well as the barriers they encounter in accessing support, 
including the stigma that surrounds problem substance use. 
It has also provided suggestions for enhancing the provision 
of supports for affected families and for challenging stigma. 
Findings of the study must be interpreted in light of the study 
limitations, however, which include the small sample size and 
the gender imbalance among participants. 
Cathy Kelleher
1 McDonagh D, Connolly N and Devaney C (2018) ‘Bury don’t 
discuss’: the help-seeking behaviour of family members 
affected by substance-use disorders. Child Care in Practice, 
[Early online] https://www.drugsandalcohol.ie/28867/ 
Help-seeking behaviours of 
family members continued
An Garda Síochána 
Policing Plan 2017
An Garda Síochána Annual Policing Plan 2018 identifies the 
main policing concerns for 2018 as prioritised by An Garda 
Sióchána (AGS) and in support of the AGS Strategy Statement 
July 2016—2018.1,2 It considers priorities identified by the 
Minister of Justice and Equality and the Policing Authority along 
with the views of external stakeholders and the general public. 
It contains several ‘concrete measurable initiatives’ (p. 2) and 
will attempt to implement several recommendations from the 
Garda Inspectorate Report Changing policing in Ireland.3 As in 
previous plans, several areas have been highlighted by AGS in 
2018: organisational development and capacity improvement; 
national and international security; confronting crime; roads 
policing; and community engagement and public safety. 
Organisational development and  
capacity improvement
With the ongoing aim of renewing AGS culture and advancing 
the Modernisation and Renewal Programme 2016—2021,4 
AGS has prioritised the following areas: composition 
and structure of the Garda workforce; Garda resource 
deployment; supervision; improved data quality; cultural 
renewal; and enhanced governance. 
National and international security
To ensure that Ireland is a safe and secure place to reside, 
work, visit and invest, AGS will continue to monitor domestic 
and international security by carrying out intelligence-led 
operations against terrorism, risk assessment, and operational 
preparation for major emergencies in conjunction with major 
emergency management partners. They will collaborate 
and build on relationships with other security partners, the 
Police Service of Northern Ireland (PSNI) and international 
agencies. AGS intends to fully participate in bilateral 
European and international security meetings and support 
associated security initiatives. Additionally, preparations and 
implementation of the Schengen Information System (SIS II) are 
ongoing. AGS also aims to develop a cybercrime and security 
strategy to increase the capacity to avert and act against 
cybercrime security incidents.
Confronting crime
AGS is committed to the prevention of crime along with 
advocating for the rights of victims exposed to crime. 
Initiatives put forward aim to help AGS achieve this outcome 
and include: implementing the EU Victims Directive; 
supporting victims of sexual crime and domestic violence 
as well as collaborating with other agencies to implement a 
national action plan. AGS plans to implement their National 
Crime Prevention and Reduction Strategy nationally and will 
carry on targeting assaults, burglaries and robberies using 
a multiagency and intelligence-led approach.5 In addition, 
Operation Thor is to be refocused towards averting violent 
crime. Measures to prevent and investigate non-violent, 
financially motivated crime will include targeting fraud, 
corruption and bribery. Organised crime groups will be 
targeted using intelligence-led operations. Success will 
be appraised via submission of progress reports to the 
Policing Authority, higher controlled drugs detections and 
firearm seizures. In addition, it is hoped that the results of 
an evaluation of the Drug-Related Intimidation Reporting 
Programme will be available by the end of 2018.
Roads policing
Saving lives is viewed as essential to AGS. One area that can 
be focused on to achieve this is road safety by targeting key 
lifesaver offences, such as not wearing seatbelts, driving 
while on a mobile phone, speeding, and driving while under 
the influence of alcohol and drugs. Divisional Roads Policing 
Units are to be established and the increase in personnel 
in this area is ongoing. Inappropriate road-user behaviour 
will be targeted via increased use of social media to 
communicate road safety messages. 
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who will then report to the Garda Commissioner and the 
Policing Authority once a month. The acting commissioner 
believes that this plan will ‘redouble efforts to deliver a 
policing and security service that the people of Ireland 
are proud of’ and he is ‘confident that AGS will deliver an 
excellent and continuously improving policing and security 
service for the people it serves’ (p. 2).1
Ciara H Guiney  
1 An Garda Síochána (2018) An Garda Síochána Annual  
Policing Plan 2018. Dublin: An Garda Síochána.  
https://www.drugsandalcohol.ie/29169/
2 An Garda Síochána (2016) An Garda Síochána strategy  
statement July 2016—2018. Dublin: An Garda Síochána.  
https://www.drugsandalcohol.ie/27305/ 
3 Garda Síochána Inspectorate (2015) Changing policing in Ireland: 
delivering a visible, accessible and responsive service. Dublin: 
Garda Síochána Inspectorate. Available online at http://www.
gsinsp.ie/en/GSINSP/1286-ChangingPolicinginIreland_Low-Full.
pdf/Files/1286-ChangingPolicinginIreland_Low-Full.pdf 
4 An Garda Síochána (2015) An Garda Síochána modernisation 
and renewal programme 2016—2021. Dublin: An Garda Síochána. 
http://www.drugsandalcohol.ie/27306/
5 An Garda Síochána (2017) Crime prevention and reduction strategy: 
putting prevention first. Dublin: An Garda Sióchána. https://www.
drugsandalcohol.ie/27147/ 
In addition, AGS will collaborate with other agencies, such as 
the Road Safety Authority, Transport Infrastructure Ireland 
and road safety officers to reduce deaths and serious 
injuries. 
Community engagement and public safety 
An approach used by AGS that increases community 
engagement and public safety is community policing. Several 
initiatives are planned. For example, AGS will implement 
the first phase of a new integrated system – Segmentation, 
Targeting, Analysing, Responding, Tracking (START) and create 
a strategy to incorporate the Garda Reserve into community 
policing structures. It will draw on digital platforms to 
provide information on AGS and its ongoing operations. 
Offender management will be improved on by advancing and 
refining the current multiagency approach.
Key policing and security priorities 2018
Table 1 outlines a summary of AGS’s key policing and security 
priorities for 2018. Responsibility for actioning and reporting 
on the progress of each initiative of this plan has been 
assigned to an assistant commissioner or executive director 
Table 1: Policing and security priorities 2018
Priorities Areas targeted
Confronting crime Organised crime
 
 
• Drugs
 • Human trafficking
• Cross-border crime
 • Brexit preparedness
Crimes against the person and property
 
 
 
 
 
• Sexual offences
 • Illegal weapons
 • Robberies
 • Assaults
 • Domestic violence 
 • Burglary 
Cybercrime
White collar crime/fraud
Community policing  
and public safety
 
 
Victims • Victim satisfaction
 • Vulnerable victims
 • Hate crime
Major incident planning
Community policing and antisocial behaviour
Crime prevention
Garda visibility
Roads policing Safeguarding road users
 Denying criminals the use of roads
Organisational capacity  
improvement
 
 
 
Implementation of the code of ethics
Organisation development •  Modernisation and renewal programme
 • Civilianisation
• Supervision
 • Cultural audit
 • Third-party reports
Data quality, governance and stewardship
 Quality of crime investigation
Security priority of the Minister for Justice and Equality
To safeguard the security of the State by protecting the State and its people from terrorism and any other security  
threats to the State
Source: Adapted from AGS, 2018, p.231
An Garda Síochána Policing  
Plan 2017 continued
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18 2  Address the funding reductions in recent years to 
community and youth projects in the area of drug misuse 
prevention and education. This should focus on enabling 
groups to upscale training outreach and peer-to-peer 
education work in community and school settings.
3  Support the development of more youth-friendly 
education materials that provide factually accurate 
information, including an emphasis on areas viewed as 
under-represented (e.g. cannabis and alcohol misuse; the 
link between drug misuse and sexual health; and the link 
between social media and mental health).
4  Ensure young people are heard, for example, through 
the establishment of a continuous feedback from young 
people on the effectiveness, or otherwise, of substance 
misuse strategies.
5  Build a stronger evidence base to show the impact of 
substance misuse education. Draw on evidence from 
international best practice. This should not put further 
pressure on community organisations or teachers 
but could be done through forming partnerships with 
interested educators and universities.
6  Start drug misuse education earlier through the pilot 
of primary-level programmes, learning from ongoing 
education work on wellbeing in the primary education 
and community sectors.
7  Promote stronger advocacy from Drug and Alcohol Task 
Forces on:
 –  Areas of Government policy and legislation relating to 
substance misuse, for example, learning lessons from 
the Public Health (Alcohol) Bill 2015
 –  The central question of social and economic 
inequality and its connection with substance misuse.
8  Provide support for an interagency collaborative 
approach to education, awareness, and intervention on 
substance misuse.
9  Continue to support the essential roles of the key 
stakeholders, including statutory agencies, the 
Department of Education, community and youth 
projects, schools, parents and carers.
10  Ensure that any actions relating to Dublin’s north inner 
city respond appropriately to the particularly difficult and 
tense atmosphere there at this time.
Lucy Dillon
1 Department of Health (2017) Reducing harm, supporting 
recovery: a health-led response to drug and alcohol use  
in Ireland 2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/
2 North Inner City Drug and Alcohol Task Force (2017) Report  
of ‘Let’s get specific’ prevention and education forum.  
Dublin: North Inner City Drug and Alcohol Task Force.  
https://www.drugsandalcohol.ie/29220/
Let’s get specific –  
a prevention forum
In November 2017, the Prevention and Education 
Subcommittee of Dublin’s North Inner City Drug and Alcohol 
Task Force (NICDATF) held a forum on substance misuse 
prevention and education. It was opened by Minister of 
State Catherine Byrne TD and attended by youth and 
community workers and teachers, alongside a small number 
of young people. The forum was held in the context of the 
2017 national drugs and alcohol strategy, Reducing harm, 
supporting recovery.1 The new strategy had moved away 
from having prevention as one of a set of strategic pillars to 
prevention actions falling under a broader goal that sets out 
to promote and protect health and wellbeing. 
The forum set out to discuss prevention in the new strategy 
and the work of and issues faced by those working in 
prevention and education. On 15 June 2018, NICDATF 
launched a report Let’s get specific, which detailed the 
discussions at the forum.2 The report is divided into four 
sections:
• The first describes participants’ responses to the new 
strategy and their views on the broad context in which 
they were working. 
• The second reflects the discussion on substance misuse 
prevention and education in schools, with a strong focus 
on the Social, Personal and Health Education (SPHE) 
programme. 
• The third describes the work of youth and community 
services providing prevention education and therapeutic 
support and treatment to young people. 
• The final section makes a set of recommendations. 
Recommendations
The main body of the report presents participants’ 
perceptions on each of the areas covered, including what 
they saw to be as the main challenges and obstacles to 
delivering effective prevention and education programmes. 
In the concluding section, the Prevention and Education 
Subcommittee of NICDATF makes 10 recommendations, 
which broadly reflect the views and experiences of forum 
participants. These are:
1  Work with the Department of Education to enhance 
the status of and support to the teaching of SPHE. This 
should include:
 –  Proper staffing of its teaching. SPHE should not be 
treated as an ‘add on’ subject.
 –  Provision of adequate training and support to SPHE 
teachers.
 –  Leadership of school principals in ensuring proper 
timetabling of the subject; connecting the teaching 
of the subject with external support groups in 
the community; and sharing the lessons with, and 
involving, parents in training.
23
Issue 67 | Autum
n 20
18
     drugnet IR
ELAN
D
      
Single scheme
Since the review, work has been ongoing at the DCYA to 
implement its recommendations. In the meantime, the 
programmes have continued to be funded: in 2012, the 
combined spend on the three programmes was €39.7m 
and by 2017 this had reduced to €36.8m. To deliver on the 
recommendations, the DCYA has undertaken an extensive 
programme of work including reviewing evidence and 
stakeholder engagement. This is informing the development 
of a single funding scheme that aims to ‘replace the 
existing funding programmes with a single fit-for-purpose 
youth scheme, targeting disadvantaged young people with 
evidence informed interventions and services that will 
secure good outcomes’ (p. 4).2 For the purpose of the design 
and development phase of the process, the new scheme is 
referred to as the Targeted Youth Funding Scheme (TYFS).
The purpose of the TYFS is ‘to support young people to 
overcome adverse circumstances by strengthening their 
personal and social competencies’ (p. 6).2 Therefore, 
it is based on a belief that building on these so-called 
‘soft’ outcomes will impact positively on outcomes such 
as employability, developing career aspirations, and 
decreasing violent behaviour and drug use. The programme 
will therefore primarily focus on intervening at the level 
of the individual young person. The TYFS has identified 
seven personal and social development competencies as 
core to the programme: communication skills; confidence 
and agency; planning and problem-solving; relationships; 
resilience and determination; self-discipline; and, emotional 
intelligence. 
Within the three target groups identified for the programme 
are those young people experiencing economic and 
social and cultural disadvantage, including those living in 
communities with high concentrations of addiction, as well 
as those who are ‘vulnerable or at risk’, including those 
considered so because of substance use. Stakeholder 
engagement is ongoing in the restructuring of these 
programmes and it is expected that the first cycle of the new 
structure will begin in January 2020. 
Lucy Dillon
1 Department of Children and Youth Affairs (2014) Value for 
money and policy review of youth programmes. Dublin: 
Government Publications. https://www.drugsandalcohol.
ie/23242/
2 Department of Children and Youth Affairs (2018) Unpublished 
internal circular on ‘Stakeholder engagement: Targeted Youth 
Funding Scheme. Scheme outline April 2018’.
Prevention 
interventions 
targeting at-risk 
youth: Targeted 
Youth Funding 
Scheme
Based on the recommendations of a value-for-money and 
policy review,1 the Department of Children and Youth Affairs 
(DCYA) is developing a single ‘fit-for-purpose youth scheme’. 
Value-for-money review
In 2014, the DCYA published a value-for-money and policy 
review of three youth programmes targeting youth at risk: 
the Special Projects for Youth (SPY); the Young People’s 
Facilities and Services Fund (YPFSF); and the Local Drugs 
Task Force (LDTF) projects.1 While the three programmes 
have different origins, they share similar objectives and 
target similar groups of young people. The programmes 
generally target 10–21-year-olds in areas characterised 
by problem drug use, educational disadvantage, criminal 
activity, unemployment, and homelessness. Preventing the 
onset of or reducing drug-taking is a common focus of 
the three programmes. The review highlighted the ongoing 
social and economic challenges being faced by young 
people in Ireland and concluded that ‘there remains a 
valid rationale for the provision of youth programmes for 
young people who are disadvantaged’ (p. 67).1 However, the 
review was heavily critical of the governance structures 
underpinning the three programmes and the lack of 
conclusive evidence relating to their efficacy, that is, a 
lack of effective performance measurement. However, 
it also argued that ‘there is promising academic support 
that, effectively harnessed, these programmes can make 
a difference’ (p. 10).1 It therefore called for ‘significant 
reform’ (p. 10)1 of the programmes and of their performance 
governance arrangements and, to this end, made a set of 12 
recommendations. 
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18 is to ‘strategically tackle harms associated with alcohol 
consumption among third-level students’. Evaluation of this 
programme is currently underway; therefore, evaluation 
findings from the programme are not yet available. However, 
a paper has been published outlining the study protocol for 
developing, implementing, and evaluating the programme.2
The REACT programme
REACT is defined as a multicomponent intervention. It is 
described by the paper’s authors as forming part of the 
wider Health Promoting University ethos endorsed by the 
World Health Organization.3 The concept of the Health 
Promoting University ‘means much more than health 
education for students and staff – it means integrating 
health into the culture, processes and policies of the 
university’ (p. 5). A defining feature of the programme is that 
it is an environmental rather than an educational initiative. 
Development of the programme was based on a three-step 
process involving a review of international best practice, 
a knowledge exchange forum, and expert consultation. 
The programme ‘seeks to establish a specially tailored 
accreditation and award system for third-level institutions 
(colleges/universities/institutes of technology) that make 
significant changes within their campuses to tackle the 
growing issue of excessive alcohol consumption among 
students’ (p. 2).2
Responding to 
excessive alcohol 
consumption in 
third-level (REACT):  
a study protocol
High levels of alcohol use have been found among third-level 
students in Ireland. In 2014, the Health Service Executive 
(HSE) commissioned a research team to develop a public 
health intervention to address alcohol use among third-level 
students. Responding to Excessive Alcohol Consumption in 
Third-level (REACT)1 was developed in collaboration between 
the Health Matters team at University College Cork, the Irish 
Student Health Association, and the Union of Students in 
Ireland (USI). 
REACT is currently being implemented in 15 higher education 
institutions across Ireland (personal communication, 
REACT project, June 2018). The aim of the programme 
Table 1: Mandatory action points of the REACT Award Scheme
Action point Description
1 All incoming students are strongly 
encouraged to take an online brief 
intervention tool 
A target of 33% of incoming first-year students to have completed e-PUB (or 
other brief intervention tool if already in place) must be met before a college/
university/institute of technology is deemed to have achieved this mandatory 
action point. Statistics should be presented to a relevant college committee on 
an annual basis 
2 Develop a college alcohol policy in 
line with the ‘National Framework to 
Develop a College Alcohol Policy’ 
Develop a college alcohol policy in line with the ‘National Framework to Develop 
a College Alcohol Policy’ 
3 President of the college commits to 
the REACT programme 
The President of the college (or equivalent management figure) signs a 3 year 
commitment to the college actively pursuing the criteria set out by the REACT 
programmes Action Point List 
4 Form a Steering Committee of staff 
and students, chaired by a senior 
college official, that meet twice 
a year (minimum) and review the 
Action Plan annually 
Form a Steering Committee which will: 
a) Have student and staff representation
b) Be chaired by a senior college official
c)  Have a member of the Gardaí, a member of the local council and a  
member of the Local Drugs and Alcohol Task Force as committee members
d) Meet a minimum of twice a year
e) Review the college Alcohol Action Plan annually
5 Safety issues in the context of 
alcohol must be considered while 
planning all large scale students 
events 
An agenda item of alcohol and safety issues must be present and discussed 
on the agenda of all SU, Societies and Clubs planning meetings related to any 
large scale student entertainment events at which alcohol will be available, e.g. 
College Balls, Gigs, R&G, etc. 
6 Establish a tracking and reporting 
mechanism for key alcohol related 
harm indicators 
Establish a tracking and reporting mechanism that will track key alcohol related 
harm indicators, e.g. injuries, anti-social behaviour, harm to relationships, 
studies, etc. 
7 The college completes its own 
evaluation of the effectiveness of the 
alcohol action plan every 3 years 
The college devises and completes an evaluation strategy to monitor the 
effectiveness of the alcohol action plan every 3 years 
8 Train relevant staff in Brief 
Intervention Training 
Ensure key individuals in student health and the student experience are able 
to deliver Brief Intervention Therapy around alcohol misuse and have a clear 
understanding of the internal referral pathways 
Source: http://reactalcohol.ie/
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ranking. Institutions can then apply to the REACT team for their 
award. Once the application is received, an evaluator will be 
appointed to meet with the institution’s steering committee 
to discuss the implementation and associated accreditation/
award. The details of the content of the accreditation/award 
were under development at the time of writing.
Participating third-level institutions are required to carry 
out activities from a suite of mandatory and optional action 
points. Lists of these are provided below (see Tables 1 and 2). 
The participating institution must complete all eight of the 
action points in Table 1 as well as 16 points from the actions in 
Table 2, including at least two action points of a ‘three point’ 
REACT continued
Table 2: Optional action points of the REACT Award Scheme
Action point Description
1 Designate a specific college official to have overall 
responsibility for the REACT project (1 point) 
Designate a specific college official to have overall responsibility for 
the college’s REACT programme 
2 Develop a calendar of events in conjunction with 
local Students’ Union (2 points) 
Develop a calendar of events in conjunction with local Students’ 
Union which requires proactive planning 
3 Develop reporting mechanism for tracking high 
risk promotions by local licensees (3 points) 
Develop reporting mechanism for tracking high risk promotions by 
local licensees
4 REACT Training Toolkit is utilised at class rep 
training to provide them with relevant safety 
information (1 point) 
a)  The REACT Training Toolkit (available via the WebApp) is utilised 
for a session at class rep training annually with a special emphasis 
placed upon safety 
b)  Members of Clubs and Societies for which this would hold 
relevance in event planning are invited to this training
5 Alcohol counselling service available to students 
(3 points) 
Provide an alcohol counselling service to the student body 
6 Hold an annual meeting with local stakeholders 
(1 point) 
Hold a minimum of one meeting annually with local stakeholders 
(e.g. local Gardaí, local residents, local businesses, etc.) as a forum 
to discuss grievances and suggestions related to students excessive 
alcohol consumption 
7 Develop a visible and accessible referral pathway 
to a range of internal and external alcohol 
support services for students (2 points) 
Develop a visible and accessible referral pathway to a range of internal 
and external alcohol support services for students. In addition: 
a)  The pathway will include and promote a self-referral route for 
students
b)  Training and information relating to the pathway is to be offered 
to front line staff of the college every two years
8 Provide alcohol free housing and alcohol free 
social spaces (3 points) 
Provide: 
a) Alcohol free housing
b) Alcohol free social spaces
9 Partnerships developed with relevant local 
community groups (1 point) 
Partnerships developed with relevant local community groups (e.g. 
local council, healthy cities committee, etc.) 
10 Provide late night transport to student 
accommodation (2 points) 
Provide late night transport to student accommodation for college 
events/nights out 
11 Develop and implement a Student Community 
Support system (3 points) 
Develop and implement a Student Community Support system for 
key student weeks (e.g. R&G Week, Freshers’ Week, etc.) 
12 Allocate space for Alcoholics Anonymous 
(2 points) 
Make contact with and allocate space for Alcoholics Anonymous to 
hold meetings for college students 
13 Map local licensed premises (2 points) Map and update (every 2 years) all local licensed premises 
14 Require RSA training for all on campus bar staff 
(2 points) 
Require Responsible Serving of Alcohol (RSA) training for all on 
campus bar staff
15 Use the Alcohol Use Disorders Identification 
Test (AUDIT) as preferred measure of drinking 
patterns and alcohol-related harm (3 points) 
Use AUDIT scale when measuring drinking patterns and alcohol 
related harm in health research projects focused on students 
16 Conduct robust qualitative alcohol related 
research with students (3 points) 
Conduct a high level alcohol related qualitative research project 
with students 
17 Enable PhD/Academic researcher to conduct a 
study on your Action Plan (3 points) 
Enable PhD/Academic researcher to conduct a study on the 
effectiveness of the interventions within your Action Plan 
18 Provide all of the relevant college data related 
to the Action Plan to the National REACT co-
ordinator/researcher (3 points) 
Provide all of the relevant college data related to the Action Plan 
to the National REACT co-ordinator/researcher for inclusion in 
national research 
Source: http://reactalcohol.ie/
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18 Alongside the impact evaluation, a qualitative study will be 
conducted to explore perceived factors influencing the 
take-up and implementation of the programme. Research 
examining students’ views on the programme and on alcohol 
more generally will be carried out in a separate study. 
The authors highlight that the REACT programme ‘provides 
a structure to translate policy into practice and to tackle 
hazardous alcohol consumption and related harms among 
third-level students’ (p. 7). The 15 institutions currently 
signed up to the programme are in the process of 
implementing the mandatory and optional action points. The 
REACT team are working on developing the accreditation 
framework for the programme and aim to have their first 
accreditation by 2019.1
Lucy Dillon
1 For further information on the programme, visit  
http://reactalcohol.ie/
2 Davoren MP, Calnan S, Mulcahy J, Lynch E, Perry IJ and Byrne M 
(2018) Responding to excessive alcohol consumption in third-level 
(REACT): a study protocol. BMC Health Services Research, 18(1): 
364. https://www.drugsandalcohol.ie/29015/
3 Tsouros AD, Dowding G, Thompson J and Dooris M (eds) (1998) 
Health promoting universities: concept, experience and 
framework for action. p. 174. Copenhagen: World Health 
Organization Regional Office for Europe.  
https://www.drugsandalcohol.ie/29173/ 
Implementation and evaluation
REACT will be implemented and evaluated in line with 
the UK Medical Research Council’s framework guidelines, 
which aim to help researchers and research funders to 
recognise and adopt appropriate methods for working 
on complex interventions (those containing several 
interacting components). The framework identifies 
several phases involved in the process of developing and 
evaluating a complex intervention, although these phases 
may not necessarily follow a linear sequence: developing 
an intervention, piloting and feasibility, evaluating the 
intervention, and implementation.
The REACT evaluation will consist of a number of elements. To 
begin with, a baseline and follow-up cross-sectional study will 
be conducted to determine any potential impact of the REACT 
programme. This study will examine alcohol consumption 
levels and other related behaviours as well as attitudes among 
students. It will incorporate the AUDIT (Alcohol Use Disorders 
Identification Test) and other questions based on a review of 
national and international research. 
The baseline study was conducted at the end of 2016 
(n=1873), and the follow-up study is due to be repeated in 
the same institutions in the autumn of 2018. 
REACT continued
Optimising treatment 
in opioid dependency 
in primary care
The majority of opioid agonist treatment (OAT) in Ireland is 
provided through general practitioners (GPs), who undergo 
additional training, and through the Methadone Treatment 
Programme (MTP), which has been running for 20 years. 
Over this period, however, misuse of over-the-counter (OTC) 
and prescription medication use has increased. Increases in 
waiting times for treatment and drug-related deaths have 
occurred despite a scaling up of OAT in Ireland. The aim of 
this study1 was to make recommendations to improve OAT 
and MTP treatment. 
Methods
A single focus group containing 11 pre-selected national 
key stakeholders and experts took part in a guided one-off 
discussion. A broad range of expertise was represented, 
including clinical, addiction and social inclusion management, 
harm reduction, homelessness, specialist GPs, and 
academics. Three participants came from national non-
statutory agencies, while the majority of the panel oversaw 
OAT design and implementation. A written guide exploring 
relevant issues around OAT and MTP was used in the focus 
group discussion. Transcripts of the audio recording were 
subjected to content analysis to generate overall themes. 
Results
Four themes emerged from the content analysis of the 
discussion on current barriers within treatment and possible 
solutions: OAT choices and patient characteristics; systemic 
barriers to optimal OAT service provision; GP training 
and registration in the MTP; and solutions and models of 
good practice: using what you have. The main barriers and 
solutions raised were as follows.
OAT choices and patient characteristics 
• There was lack of choice in OAT; Suboxone® use is 
restricted, whereas methadone is widely available yet 
viewed more negatively by patients. 
• There was a change in characteristics of those seeking 
OAT; with OTC opioid abuse becoming more prevalent, 
accessing treatment is proving difficult for the new 
cohort of patients both in terms of location and stigma 
associated with some addiction services.
• Treatment pathways for polydrug use are lacking.
• Patients’ behavioural issues often require measures at 
methadone dispensing pharmacies. This was keenly felt in 
regard to all female practices supervising male patients.
•  The age profile of long-term methadone users may limit 
the relevance of any new treatment models.
•  The current long-term MTP was described as complex 
and overly medicalised (e.g. tapering) and requires a 
broader approach.
Systemic barriers to optimal OAT service provision 
•  Provision of OAT was described as urban-centric, 
creating a logistical barrier for rural patients.
•  The sole route of treatment is often through large 
methadone clinics that may be off-putting for some 
patients.
•  Complexities around patient’s addresses can limit the 
available services.
•  Waiting lists for treatment and the requirement for 
regular consultations exist.
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•  Family support systems should be used from the outset, in 
addition to shared care and key working.
•  The potential for community pharmacies and nurses to 
contribute to care, including necessary vaccinations, 
should be realised.
Conclusions
This study was a first step in identifying barriers to optimal 
OAT provision. Key experts identified a number of possible 
solutions that the Irish College of General Practitioners (ICGP) 
will seek to advance in the relevant arenas and expand upon 
through further independently run research.
Limitations
The authors acknowledge a number of limitations to the 
research, including the use of a single focus group containing 
11 pre-selected experts; the sample not likely to be nationally 
representative of experiences or opinions; no patient voices 
were included; and involvement of members of the ICGP’s 
Substance Misuse Programme in discussion and facilitation 
may have limited the views shared by others in the group.
Michael O’Sullivan
1 Van Hout MC, Crowley D, McBride A and Delargy I (2018) 
Optimising treatment in opioid dependency in primary care: 
results from a national key stakeholder and expert focus group  
in Ireland. BMC Family Practice, 19(1): 103.  
https://www.drugsandalcohol.ie/29270/ 
2 Level 1 refers to GPs trained in addiction treatment but not to an 
advanced level. Level 2 registration refers to GPs with advanced 
addiction specialist training.
•  Stipulations on referring patients to Level 1 GPs2 and 
restrictions in numbers managed by Level 1 GPs exist.
GP training and registration in the MTP
•  Complexity around registration with the Health Service 
Executive (HSE) and the negative perception of OAT were 
viewed as affecting the uptake of Level 1 and 2 training. 
•  GP registrars not exposed to the opioid-dependent 
cohort were seen to be less willing to be involved in 
training and OAT.
•  Level 1 and 2 structures were viewed as too complex for 
new GPs entering employment in services that do not 
currently have MTP. 
•  Difficulties around becoming a Level 2 prescriber exist. 
•  In some areas, GPs were seen as unwilling to take on 
complex patients due to a lack of resources. 
Solutions and models of good practice: using what you have
•  The training of all GPs in methadone prescribing and 
other OAT was seen as a way to change attitudes.
•  Supports, such as counselling, that are available in clinics 
should be available in some capacity to GP services.
•  Informal support meetings within GP practices or 
telemedicine to deal with the complexity of some cases 
should be available.
Opioid dependency in  
primary care continued
Reducing the harms 
of cocaine use in 
Ireland
On 17 July 2018, a new campaign developed by the Ana 
Liffey Drug Project and the Health Service Executive (HSE) 
was launched to raise awareness of the dangers of using 
cocaine (powder and crack) and on how to reduce the harms 
associated with snorting, smoking or injecting cocaine.1 
The Republic of Ireland currently ranks fourth highest in 
the European Union for cocaine use among young adults. 
In addition, cocaine remains the third most common drug 
reported among people presenting to treatment services in 
Ireland; in 2016, 12.3% of cases reported problem cocaine 
use, the highest proportion since 2010. While the campaign 
will stress that it is always safest not to take unknown or illicit 
drugs at all, if a person chooses to use cocaine, the campaign 
provides harm reduction advice. This includes the following:
•  When buying, know the source and avoid using alone.
•  Use one drug at a time.
•  Start with a small test dose and leave at least two hours 
between doses.
•  Grind cocaine to remove small lumps; use a sterile straw 
and do not share.
•  Carry a condom as cocaine use may increase sex drive 
and lead to unprotected sex.
Research indicates that regular clubgoers and people that are 
part of the club/dance music scene have higher rates of drug 
use compared to the general population. With this in mind, 
the awareness campaign will target clubs and public event 
spaces, colleges, and addiction services with information 
about cocaine powder. In addition, drug services, clinics, 
and Drug and Alcohol Task Forces will be targeted with 
information about crack.
Minister of State for Health Promotion and the National Drugs 
Strategy, Catherine Byrne TD, welcomed the campaign and 
stated: 
This is a very important campaign, focusing on providing 
information and raising awareness about cocaine among 
drug users and health professionals .... Through our 
national drugs strategy, ‘Reducing Harm, Supporting 
Recovery’, we are working to strengthen early harm 
reduction responses to current and emerging trends and 
patterns of drug use, which would benefit people who use 
drugs, their families and the community.
Seán Millar 
1 Health Service Executive (2018) Cocaine – reduce the harms. 
Dublin: Health Service Executive. Available online at: https://
www.hse.ie/eng/services/news/media/pressrel/cocaine-
reduce-the-harms.html
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18 declined significantly from baseline to month 3 (p<0.001) 
and from month 3 to month 12 (p=0.01). Use of other drugs 
did not change significantly. Among factors associated with 
heroin abstinence, the study observed the following: 
• None of the patients who had a previous psychiatric 
admission were abstinent (p=0.02).
• All of the patients who were using cocaine during month 
12 were also using heroin (p=0.02).
• Abstinence was not significantly associated with a higher 
medication dose (p=0.88).
• Early reductions in heroin use, as evidenced by provision 
of at least one heroin negative sample during induction, 
tended to be associated with reduced likelihood of 
heroin abstinence at month 12 (p=0.07).
Cox regression analyses indicated that patients who had 
no children, grew up in families with two parents, were in 
an intimate relationship with another heroin user, and who 
were abstinent from cocaine in pre-treatment drug screens 
demonstrated significantly lower rates of unplanned exit 
from treatment.
Conclusions
The authors concluded that the study confirmed that 
adolescents on OST can achieve substantial reductions 
in heroin use, with many doing so very early in treatment. 
In addition, after a year of treatment, almost one-half of 
adolescent heroin users were heroin-abstinent. The authors 
state that these findings should act as source of optimism 
for clinicians. Nevertheless, patient dropout from treatment 
remains a challenge and cocaine use before and during 
treatment may be a negative prognostic factor.
Seán Millar 
1 Hay G, Jaddoa A, Oyston J, Webster J, Van Hout MC and Rael 
dos Santos A (2017) Estimating the prevalence of problematic 
opiate use in Ireland using indirect statistical methods. Dublin: 
National Advisory Committee on Drugs and Alcohol. https://
www.drugsandalcohol.ie/27233/ 
2 Smyth BP, Elmusharaf K and Cullen W (2018) Opioid substitution 
treatment and heroin dependent adolescents: reductions in 
heroin use and treatment retention over twelve months. BMC 
Pediatrics, 18: 151. https://www.drugsandalcohol.ie/29019/ 
Opioid substitution 
treatment for 
heroin-dependent 
adolescents
Opioid dependence is a major health concern across the 
world. The most recent prevalence estimates of opiate use 
in the Republic of Ireland indicate that there were 18,988 
opioid users in Ireland in 2014, giving a rate of 6.18 per 
thousand population aged 15—64 years (95% CI: 6.09—6.98).1 
Six per cent of this estimated population was under 24 years 
of age. Although recent trends suggest that the prevalence 
of problem opiate use in Ireland may have stabilised, it 
should be noted that estimates remain high, with other 
comparable studies suggesting that rates of use remain 
among the highest in Europe. Opioid substitution treatment 
(OST) is the main first-line treatment intervention for heroin 
dependence among adults. Nevertheless, while OST has 
been thoroughly evaluated in adult populations, few studies 
have examined its use in younger age groups, and there are 
concerns that OST is underutilised in adolescents with heroin 
dependence.
A recent Irish study investigated changes in drug use among 
adolescents receiving OST and also examined treatment 
attrition during the first 12 months of treatment.2 In this 
study, published in the BMC journal Pediatrics, data on 
all heroin-dependent patients (aged under 18.5 years) 
commencing OST were examined from one outpatient 
multidisciplinary addiction treatment service in Dublin. Drug 
use was monitored twice weekly using a urine drug screen 
(UDS). Change in the proportion of UDS negative for heroin 
was examined using the Wilcoxon signed-rank test. Attrition 
was explored via a Cox regression multivariate analysis.
Results 
It was found that of 120 patients who commenced OST (51% 
female, mean age 17.3 years), 33% (n=39) persisted with OST 
until month 12. Of these patients, heroin abstinence was 
21% at month 3 and 46% at month 12, although heroin use 
Tabor Group annual 
report, 2017
The Tabor Group is a provider of residential addiction 
treatment services in Ireland. It aims to offer hope, 
healing, and recovery to clients suffering from addictions 
through integrated and caring services. In addition to three 
residential facilities, the organisation provides a continuing 
care programme to clients who have completed treatment in 
order to assist with their recovery. It also offers counselling 
to families whose loved ones are struggling with an addiction. 
In June 2018, the Tabor Group published its annual report.1 
This article highlights services provided by the Tabor Group 
to individuals with a substance use addiction in 2017.
Tabor Lodge: residential addiction treatment 
centre
Tabor Lodge is a residential addiction treatment centre 
for the treatment of people addicted to alcohol, drugs, 
gambling, and food. It is situated 15 miles south of Cork city. 
Tabor Lodge is guided by the Minnesota Model of addiction 
treatment in delivering its treatment programme. This model 
is characterised by the understanding that addiction is 
primarily a substance use disorder. The primary focus of the 
treatment programme is to educate clients on the dynamics 
of this disorder as they manifest in the life of the individual. 
Another important focus of the treatment programme is to 
assist clients develop the skills necessary to manage their 
disorder while going forward in their lives.
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In 2017, some 49 clients were admitted to Fellowship House 
for extended treatment: 13 of these were referred directly 
from Tabor Lodge and 36 were referrals from other centres 
around Ireland. A total of 36 individuals completed the 
programme. A breakdown of the specific drug of choice for 
admissions to Fellowship House in 2017 is shown in Table 
2. The report observed that cannabis remains high at 90%, 
with alcohol and ecstasy coming a close second at 88%. 
The report also noted that a majority of clients admitted for 
treatment are presenting with polydrug use, specifically the 
use of alcohol with other drugs.
Renewal: women’s residence extended 
treatment centre
Renewal works with women who have completed a primary 
28-day treatment programme. It is a 12-week residential 
extended treatment programme where clients learn to 
find routine, balance and structure. Renewal is the only 
Minnesota Model extended treatment centre for women 
based in Ireland and was opened in 1999.
In 2017, some 46 clients were admitted to Renewal, of which 
25 completed the programme. Almost 60% of these clients 
were aged between 18 and 35 years. A breakdown of the 
specific drug of choice for admissions to Renewal in 2017 
is shown in Table 3. In this year, all of the clients admitted 
presented with a history of alcohol abuse. However, the 
report also noted that there has been a considerable rise 
in the number of young women presenting with alcohol 
addiction alone.
Table 3: Specific drug of choice for clients admitted to Renewal: 
women’s residence extended treatment centre, in 2017
Drug  
of choice
Number  
of clients
Percentage  
of clients
Alcohol 46 100%
Ecstasy 21 46%
Cannabis 31 67%
Cocaine 26 57%
Prescribed 
medication
24 52%
Heroin 7 15%
Methadone 3 7%
Speed 15 39%
LSD 6 13%
Source: Tabor Group (2018)1
In addition to group therapy, lectures and one-to-one 
counselling, the programme at Renewal also arranges 
family conferences, which help clients to reconnect with 
their families as well as educating families about addiction 
and offering them support. The programme also works in 
partnership with Tusla, the Child and Family Agency, as many 
women have children in care and need help reconnecting 
and rebuilding the parent/child relationship.
Seán Millar
1 Tabor Group (2018) Tabor Group annual report 2017. Cork: 
Tabor Group. https://www.drugsandalcohol.ie/29138/
A total of 213 clients (67% male) were admitted to Tabor 
Lodge for residential treatment of addiction in 2017, of 
whom 183 completed treatment. A breakdown of the specific 
drug of choice for admissions in 2017 is shown in Table 1. The 
report noted that clinical staff at Tabor Lodge have observed 
a changing profile of clients presenting for treatment in 
recent years, with mental health challenges and a history of 
childhood trauma becoming more evident. 
Table 1: Specific drug of choice for clients admitted to Tabor 
Lodge: residential addiction treatment centre, in 2017
Drug  
of choice
Number  
of clients
Percentage  
of clients
Opiates 18 8%
Cocaine 23 11%
Cannabis 9 4%
Alcohol 138 65%
Stimulants 3 1%
Hypnotic and sedatives 9 4%
Other substances 1 0.5%
Source: Tabor Group (2018)1
With this in mind, staff at Tabor Lodge have become more 
informed about childhood trauma as a contributing factor to 
the development of addiction, and as a hindering factor in 
efforts to manage addiction disorders. In 2017, Tabor Lodge 
responded to the greater prevalence of clients presenting 
for treatment with history of childhood trauma by initiating a 
training programme. This is to ensure Tabor Lodge becomes 
more ‘trauma informed’ as an agency treating adults vulnerable 
to the ongoing debilitating impact of childhood trauma. 
Fellowship House: men’s residence extended 
treatment centre
The extended treatment programme for men is based on the 
Hazelden Minnesota Model and promotes ‘total abstinence’. 
The aim is to build on and consolidate the work of recovery 
which has already begun in primary treatment – even if 
that treatment was not in the recent past and the client is 
struggling to maintain sobriety. 
Table 2: Specific drug of choice for clients admitted to Fellowship 
House: men’s residence extended treatment centre, in 2017
Drug  
of choice
Number  
of clients
Percentage  
of clients
Alcohol 43 88%
Ecstasy 43 88%
Cannabis 44 90%
Cocaine 42 86%
Prescribed 
medication
36 73%
Heroin 13 27%
Methadone 9 18%
Speed 36 73%
LSD 28 57%
Other/Headshop 23 47%
Source: Tabor Group (2018)1
Tabor Group continued
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Recent publications
The following abstracts are cited from published journal 
articles recently added to the repository of the HRB National 
Drugs Library at www.drugsandalcohol.ie 
PREVALENCE AND CURRENT SITUATION
Alcohol-related presentations to emergency departments in 
Ireland: a descriptive prevalence study
McNicholl B, Goggin D and O'Donovan D (2018)  
BMJ Open, 8(5): e021932 
https://www.drugsandalcohol.ie/29070/ 
The aim was to determine the prevalence of alcohol-related 
presentations in all 29 emergency departments (EDs) in 
Ireland and compare with non-alcohol-related presentations 
in order to identify opportunities for improvements in the 
quality of patient care and related data collection.
Alcohol-related presentations are a significant burden 
on EDs and ambulance services, especially in the early 
hours of Sunday mornings. Addressing the alcohol-related 
burden on EDs requires improvements in data collection 
and information systems, the development of appropriate 
interventions and related referral services and better 
preventive actions for alcohol-related harm. 
Opioid substitution treatment and heroin dependent 
adolescents: reductions in heroin use and treatment 
retention over twelve months
Smyth BP, Elmusharaf K and Cullen W (2018)  
BMC Paediatrics, 18(1): 151.  
https://www.drugsandalcohol.ie/29019/ 
Opioid dependence is a major health concern across the 
world and does also occur in adolescents. While opioid 
substitution treatment (OST) has been thoroughly evaluated 
in adult populations, very few studies have examined its use 
in adolescents. There are concerns that OST is underutilised 
in adolescents with heroin dependence. We sought to 
measure changes in drug use among adolescents receiving 
OST and also to examine treatment attrition during the first 
12 months of this treatment.
We found that heroin dependent adolescent patients 
achieved significant reductions in heroin use within three 
months of starting OST and this improved further after a year 
of treatment, about half being heroin abstinent at that stage. 
Patient drop out from treatment remains a challenge, as it is 
in adults. Cocaine use before and during treatment may be a 
negative prognostic factor.
‘An inside job’: an autobiographical account of desistance
Hart W and Healy D (2018) European Journal of Probation, 
Early online. 
https://www.drugsandalcohol.ie/29373/ 
This article presents an autobiographical account of one 
man’s journey towards a crime-free life. The narrative reveals 
a change process that is at once personal and universal, and 
describes the external forces that shaped his pathway to 
desistance as well as his experiences of personal fortitude 
and agency. In addition, it highlights the role of probation 
supervision as a catalyst for change. The autobiographical 
account is accompanied by a reflective academic 
commentary that situates these personal life experiences 
within the wider desistance literature.
Maternal alcohol consumption during pregnancy and 
the risk of autism spectrum disorders in offspring: a 
retrospective analysis of the Millennium Cohort Study 
Gallagher C, McCarthy FP, Ryan RM and Khashan AS (2018) 
Journal of Autism and Development Disorders,  
48(11): 3773–82. 
https://www.drugsandalcohol.ie/29334/ 
The objective of this retrospective analysis of the 
longitudinal Millennium Cohort Study was to examine 
whether maternal alcohol consumption in pregnancy (MACP) 
is associated with the development of childhood autism 
spectrum disorders (ASD). 
Alcohol consumption during pregnancy was not associated 
with the risk of developing ASD in this study cohort.
National Drugs Library
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affected by extrinsic sources of BCO. Improved identification 
means more smokers can be supported to stop smoking in 
early pregnancy potentially improving the short-term and 
long-term health of both mother and child.
POLICY
Ireland’s Public Health (Alcohol) Bill: a critical  
discourse analysis of industry and public health  
perspectives on the Bill 
Calnan S, Davoren MP, Perry IJ and O'Donovan Ó (2018) 
Contemporary Drug Problems, 45(2): 107–126.  
https://www.drugsandalcohol.ie/28974/ 
The proposal to introduce a Public Health (Alcohol) Bill marks 
a significant development in Ireland’s alcohol policymaking 
landscape. While the Bill has generated support from public 
health advocates, it has also raised considerable opposition, 
particularly from industry. This analysis aims to examine 
the debate around this Bill using the theoretical framework 
of critical discourse analysis and applying Carol Bacchi’s 
What’s the Problem Represented To Be critical mode of 
analysis. A key objective is to analyze the current prevailing 
representations of alcohol and its regulation in Ireland 
but also to consider what they reveal about the underlying 
governing rationality in relation to alcohol regulation. In 
particular, it questions whether the Bill signals a shift in the 
official governing rationality regarding alcohol regulation. 
The analysis illustrates how alcohol is problematized in 
markedly different ways in the debates and how such 
debates are often underpinned by multifaceted elements. 
Despite such differences, it argues that there are still signs 
of a neoliberal rhetoric emerging within the public health 
discourses, raising a question over whether the Bill and its 
supporting discourses signal a paradigmatic shift or are more 
indicative of a policy embracing hybrid forms of rule.
Harmonising alcohol consumption, sales and related 
outcomes data across the UK and Ireland: an 
insurmountable barrier to policy evaluation? 
Jordan J-A, McCann M, Katikireddi SV and Higgins K (2018) 
Drugs: Education, Prevention and Policy, Early online. 
https://www.drugsandalcohol.ie/29377/ 
We aimed to assess the comparability of Northern Ireland 
(NI) and Republic of Ireland (RoI) alcohol-related data to 
determine their suitability for evaluating the effectiveness of 
alcohol policies on alcohol consumption, sales, and related 
outcomes.
The NI and RoI consumption and sales data were found not 
to be comparable enough for use in a natural experiment 
study; comparability for hospital admission data was 
acceptable. Key barriers to comparability included variations 
in population coverage and lack of overlap in questionnaire 
topics. Data access issues made it difficult to fully determine 
data comparability for alcohol-related crime and deaths. 
By contrast, NI alcohol-related data were more comparable 
with other UK countries, making comparisons for the 
purpose of policy evaluation possible. RoI would benefit 
from identifying another economically and culturally similar 
country with comparable alcohol-related data.
Piloting online self-audit of methadone treatment in  
Irish general practice: results, reflections and  
educational outcomes
Van Hout MC, Crowley D, McBride A and Delargy I (2018) BMC 
Medical Education, 18(1): 153. 
https://www.drugsandalcohol.ie/29273/ 
The purpose of this audit is to assess the quality of care 
provided to patients against an agreed set of national 
standards, enhance learning, and promote practice 
improvement and reflective practice. The aim was to 
present an online MTP self-audit and evaluate results 
from a 12-month pilot among GPs providing methadone 
maintenance treatment (MMT) in Ireland.
Results from this audit demonstrate a high level of 
compliance with best practise MMT guidelines by Irish 
GPs providing MMT. The online self-audit process was well 
received and encouraged reflective practice. The audit 
process hinged on the individual GP's ability to review and 
critically analyse their professional practice, and manage 
change. This model of audit could be adapted and used 
to monitor the management of other chronic illnesses in 
general practice.
Optimising treatment in opioid dependency in primary  
care: results from a national key stakeholder and expert 
focus group in Ireland 
Van Hout MC, Crowley D, McBride A and Delargy I (2018)  
BMC Family Practice, 19: 103.  
https://www.drugsandalcohol.ie/29270/ 
The aim was to explore the views of national statutory and 
non-statutory stakeholders and experts on current barriers 
within the National Methadone Treatment Programme 
(MTP) and broader opioid agonist treatment (OAT) delivery 
structures in order to inform their future design and 
implementation.
The study identified a series of improvement strategies which 
could reduce barriers to access and the stigma associated 
with OAT, optimise therapeutic choices, enhance interagency 
care planning within the MTP, utilise the strengths of 
community pharmacy and nurse prescribers, and recruit and 
support methadone prescribing GPs in Ireland.
A prospective, observational study investigating the use of 
carbon monoxide screening to identify maternal smoking  
in a large university hospital in Ireland 
Reynolds CME, Egan B, Kennedy RAK, O'Malley EG, Sheehan 
SR and Turner MJ (2018) BMJ Open, 8(7): e022089.  
https://www.drugsandalcohol.ie/29376/ 
This study evaluated breath carbon monoxide (BCO) testing 
in identifying maternal smokers as well as the difference 
between disclosers and non-disclosers of smoking status. 
We also investigated if other extrinsic factors affected the 
women's BCO levels in pregnancy.
Based on self-report and BCO levels, a quarter of women 
presenting for antenatal care continued to smoke, but  
only 60% reported their smoking to midwives. BCO 
measurement is an inexpensive, practical method of 
improving identification of maternal smoking, and it was not 
Recent publications continued
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probable depression and anxiety among older females. 
Furthermore, problem drinking led to a higher likelihood 
of persistent depressive symptoms in older female 
participants. Interventions targeting problem drinking among 
older females may prevent the onset and persistence of 
depression in this population, while also decreasing the 
incidence of anxiety symptoms.
Do public expenditures on health and families relate to 
alcohol abstaining in adolescents? Multilevel study of 
adolescents in 24 countries
Vieno A, Altoè G, Kuntsche E and Elgar FJ (2018) Drug and 
Alcohol Review, 37 (Suppl 1): S120–S128.  
https://www.drugsandalcohol.ie/29379/ 
Several European countries have observed an increase in 
the proportion of adolescents that abstain from drinking 
alcohol in the last decade. The reasons for this trend remain 
underexplored. We hypothesised that more generous 
government expenditures on health services and benefits to 
families with children relate to a positive trend in abstainers.
More generous expenditures on health services and family 
benefits relate to more adolescents abstaining from alcohol.
Recent publications continued
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RESPONSES
Age-related differences in alcohol attention bias:  
a cross-sectional study
Melaugh McAteer A, Hanna D and Curran D (2018) 
Psychopharmacology, 235(8): 2387–93.  
https://www.drugsandalcohol.ie/29272/ 
Addiction models theorise that alcohol attention bias (AAB) 
for alcohol-related cues develops through a process of 
classical conditioning and that attentional processes shift 
from controlled to automatically modulated responses. At 
the point of automaticity, alcohol cues grab the attention of 
problem drinkers beyond conscious control and can trigger 
alcohol use. To fully understand this shift, AAB should be 
thought of as developing on a continuum from when alcohol 
use commences. Despite this, little is known about AAB 
differences in younger populations who are at an early stage 
in their exposure to alcohol and related cues.
This cross-sectional approach provides an insight into 
AAB across a key developmental period. It highlights that 
influential processes underpinning AAB may change and how 
rapidly it may approach automaticity. The implications of 
these findings are discussed.
Different patterns of alcohol consumption and the 
incidence and persistence of depressive and anxiety 
symptoms among older adults in Ireland: a prospective 
community-based study
Carvalho AF, Stubbs B, Maes M, Solmi M, Vancampfort D, 
Kurdyak PA, Brunoni AR, Husain MI and Koyanagi A (2018) 
Journal of Affective Disorders, 238: 651–58.  
https://www.drugsandalcohol.ie/29271/ 
The associations of different patterns of alcohol 
consumption and the incidence and persistence of 
depressive and anxiety symptoms in older age remain 
unclear.
